<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27974950</article-id><article-id pub-id-type="pmc">5126438</article-id><article-id pub-id-type="doi">10.1155/2016/2840643</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Study</subject></subj-group></article-categories><title-group><article-title>Evidence of a Redox-Dependent Regulation of Immune Responses to Exercise-Induced Inflammation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sakelliou</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8475-8411</contrib-id><name><surname>Fatouros</surname><given-names>Ioannis G.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Athanailidis</surname><given-names>Ioannis</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tsoukas</surname><given-names>Dimitrios</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chatzinikolaou</surname><given-names>Athanasios</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Draganidis</surname><given-names>Dimitris</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jamurtas</surname><given-names>Athanasios Z.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liacos</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2126-3251</contrib-id><name><surname>Papassotiriou</surname><given-names>Ioannis</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mandalidis</surname><given-names>Dimitrios</given-names></name><xref ref-type="aff" rid="I6">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Stamatelopoulos</surname><given-names>Kimon</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dimopoulos</surname><given-names>Meletios A.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mitrakou</surname><given-names>Asimina</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Clinical Therapeutics, Medical School, University of Athens, 11527 Athens, Greece</aff><aff id="I2"><sup>2</sup>School of Physical Education and Sport Sciences, University of Thessaly, Karies, 42100 Trikala, Greece</aff><aff id="I3"><sup>3</sup>School of Physical Education and Sport Sciences, Democritus University of Thrace, 69100 Komotini, Greece</aff><aff id="I4"><sup>4</sup>Department of Toxicology, Medical School, University of Athens, 11527 Athens, Greece</aff><aff id="I5"><sup>5</sup>Department of Clinical Biochemistry, &#x0201c;Aghia Sophia&#x0201d; Children's Hospital, 11527 Athens, Greece</aff><aff id="I6"><sup>6</sup>School of Physical Education and Sport Science, University of Athens, Athens, Greece</aff><author-notes><corresp id="cor1">*Ioannis G. Fatouros: <email>fatouros@otenet.gr</email></corresp><fn fn-type="other"><p>Academic Editor: Victor M. Victor</p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>15</day><month>11</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>2840643</elocation-id><history><date date-type="received"><day>14</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>21</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Alexandra Sakelliou et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>We used thiol-based antioxidant supplementation (n-acetylcysteine, NAC) to determine whether immune mobilisation following skeletal muscle microtrauma induced by exercise is redox-sensitive in healthy humans. According to a two-trial, double-blind, crossover, repeated measures design, 10 young men received either placebo or NAC (20&#x02009;mg/kg/day) immediately after a muscle-damaging exercise protocol (300 eccentric contractions) and for eight consecutive days. Blood sampling and performance assessments were performed before exercise, after exercise, and daily throughout recovery. NAC reduced the decline of reduced glutathione in erythrocytes and the increase of plasma protein carbonyls, serum TAC and erythrocyte oxidized glutathione, and TBARS and catalase activity during recovery thereby altering postexercise redox status. The rise of muscle damage and inflammatory markers (muscle strength, creatine kinase activity, CRP, proinflammatory cytokines, and adhesion molecules) was less pronounced in NAC during the first phase of recovery. The rise of leukocyte and neutrophil count was decreased by NAC after exercise. Results on immune cell subpopulations obtained by flow cytometry indicated that NAC ingestion reduced the exercise-induced rise of total macrophages, HLA<sup>+</sup> macrophages, and 11B<sup>+</sup> macrophages and abolished the exercise-induced upregulation of B lymphocytes. Natural killer cells declined only in PLA immediately after exercise. These results indicate that thiol-based antioxidant supplementation blunts immune cell mobilisation in response to exercise-induced inflammation suggesting that leukocyte mobilization may be under redox-dependent regulation.</p></abstract><funding-group><award-group><funding-source>Bodosakis Foundation</funding-source><award-id>CE-80739</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Skeletal muscle trauma may be induced by diseases (e.g., cancer, dystrophies), sepsis, toxin injection, mechanical destruction, freezing and/or intense lengthening stretches causing tissue breakdown, subcellular injury, extensive proteolysis, and muscle wasting that result in deterioration of skeletal muscle function [<xref rid="B1" ref-type="bibr">1</xref>]. Exercise-induced muscle microtrauma instigates an inflammatory reaction which is followed by a healing and/or regeneration phase that is associated with activation of myogenic cells, also known as satellite cells, and augmented protein synthesis that restores muscle's physiological structure and function [<xref rid="B2" ref-type="bibr">2</xref>]. The inflammatory and repair phases are interconnected; that is, they develop in succession while suppression of the former may hinder muscle's recovery [<xref rid="B3" ref-type="bibr">3</xref>]. Powerful eccentric exercise generates repetitive lengthening stretches of skeletal muscle that results in considerable disruption of its myofiber that is followed by an inflammatory response characterized by cytokine discharge that trigger an accumulation and/or infiltration of white blood cells into the injured area, generation of reactive oxygen species (ROS), and marked deterioration of muscle's performance [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. The impressive resemblance of the inflammatory response triggered by the nonbenign, exercise-induced muscle damage and that of muscle trauma render this type of exercise an effective human experimental model to study the mechanisms governing muscle trauma which is present in disease-associated cachexia [<xref rid="B5" ref-type="bibr">5</xref>].</p><p>Inflammatory leukocytes of myeloid origin, mainly Ly6C<sup>+</sup>/F4/80<sup>&#x02212;</sup> neutrophils, start infiltrating the traumatized skeletal muscle tissue immediately after damaging exercise (i.e., eccentric-type exercise) reaching a peak at 6&#x02013;24&#x02009;h after injury and then rapidly subsiding [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. Subsequently, phagocytic CD68<sup>+</sup>/M1 macrophages infiltrate injured muscle at 24&#x02013;48&#x02009;h after injury to complete the removal of cellular debris [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B7" ref-type="bibr">7</xref>]. These myeloid populations of leukocytes trigger the proliferation of myogenic cells via a TNF-<italic>&#x003b1;</italic>- and IL-6-dependent pathway [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. This response is mediated by proinflammatory cytokines such as IL-1b, TNF-a, IL-6, and IL-8 which are released by muscle and/or leukocytes themselves [<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>] in an NF-kB- and MAPK-dependent induction [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. Following an attenuation of M1 phagocytic macrophages, CD163<sup>+</sup>/CD206<sup>+</sup> M2 nonphagocytic macrophages invade the afflicted area in response to the action of antiinflammatory cytokines such as IL-10 and promote muscle growth and repair by stimulating satellite cells [<xref rid="B14" ref-type="bibr">14</xref>]. It has been also shown that recovery from strenuous exercise is characterized by an initial rise in total lymphocytes in the circulation and a later accelerated lymphocytopenia [<xref rid="B15" ref-type="bibr">15</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>]. This effect has also been seen following muscle-damaging exercise [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B17" ref-type="bibr">17</xref>], is more noticeable for CD4<sup>+</sup>, CD8<sup>+</sup> T-cell, and CD3<sup>&#x02212;</sup>/CD56<sup>+</sup> natural killer (NK) cell subsets, and has been linked to increased [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>] susceptibility of athletes to infections during recovery from exercise [<xref rid="B18" ref-type="bibr">18</xref>]. Although the initial increase of circulating lymphocytes has been attributed to an upregulation of their release from lymph nodes or lymphoid organs (e.g., spleen) [<xref rid="B17" ref-type="bibr">17</xref>], the later lymphocytopenia may reflect an extravasation of certain lymphocyte subsets from the circulation [<xref rid="B17" ref-type="bibr">17</xref>] or may be related to a lymphocyte infiltration into traumatized muscle [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B19" ref-type="bibr">19</xref>] although the later explanation has been challenged [<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B20" ref-type="bibr">20</xref>]. However, cytotoxic CD8<sup>+</sup> lymphocytes have been shown to infiltrate injured muscle and demolish nonnecrotic muscle cells in chronic inflammatory diseases [<xref rid="B21" ref-type="bibr">21</xref>]. Others have suggested that lymphocytopenia may be related to a reduction of lymphocytes' proliferation, microbicidal activity [<xref rid="B22" ref-type="bibr">22</xref>], and increased oxidative DNA damage and apoptosis [<xref rid="B23" ref-type="bibr">23</xref>].</p><p>ROS produced by leukocytes (due to activation of NADPH oxidase and enzymes such as xanthine oxidase and cyclooxygenase-2) in response to the action of cytokines released by injured muscle as well as by invading neutrophils not only offer antiseptic defence to the muscle but also result in drastic disturbance of muscle's redox status [<xref rid="B24" ref-type="bibr">24</xref>&#x02013;<xref rid="B26" ref-type="bibr">26</xref>]. ROS release during postexercise recovery may cause a secondary damage to both afflicted and healthy adjacent myofibers (due to oxidation of muscle's protein and lipid molecules) despite a rise in muscle's antioxidant reserves [<xref rid="B11" ref-type="bibr">11</xref>]. Reduced glutathione (GSH) is one of the main antioxidants of muscle and is used to neutralize ROS thereby producing its oxidized form (GSSG), a process that results in marked perturbation of redox status in myofibers [<xref rid="B3" ref-type="bibr">3</xref>]. It has been suggested that the GSH/GSSG couple functions as a key-controller of important redox-sensitive intracellular signaling pathways that lead to cytokine synthesis and release by the injured muscle to activate immune cell recruitment and adhesion such as nuclear transcription factor kB (NFkB) and mitogen activated protein kinases (MAPK) [<xref rid="B27" ref-type="bibr">27</xref>]. Recent evidence from our group [<xref rid="B3" ref-type="bibr">3</xref>] indicated that by attenuating the decline of GSH/GSSG following extensive muscle damage induced by eccentric exercise through administration of a potent thiol-based antioxidant, that is, N-acetylcysteine (NAC), macrophage infiltration in injured muscle, was reduced by ~30% and this response was accompanied by a blunted activation of proinflammatory cytokines and NF-kB and MAPK signaling. Supplementation of antioxidant vitamins did not affect CD4<sup>+</sup>, CD8<sup>+</sup>, naive T cells, NK cells, and proinflammatory cytokines responses following intense eccentric exercise [<xref rid="B28" ref-type="bibr">28</xref>]. In contrast, in vivo and in vitro studies have shown that alterations of GSH/GSSG status via administration of NAC may result in reduced neutrophil chemotaxis [<xref rid="B29" ref-type="bibr">29</xref>] and macrophage accumulation [<xref rid="B30" ref-type="bibr">30</xref>], by attenuating the NF-<italic>&#x003ba;</italic>B-dependent proinflammatory cytokine expression and release [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>], as well as increased lymphocyte numbers and activation by inhibiting their apoptotic rate [<xref rid="B33" ref-type="bibr">33</xref>] suggesting that immune responses in inflammatory states may be redox-dependent. However, this possibility has not been explored in humans in inflammation induced by muscle-damaging exercise. Elucidation of this possibility will shed light to the mechanisms involved in skeletal muscle trauma and aid in the development of potential treatments for diseases characterized by muscle inflammation. In this study we utilized NAC supplementation to enhance GSH stores during recovery from a very intense eccentric exercise protocol performed on an isokinetic dynamometer. We hypothesized that NAC administration alters immune cell responses following exercise-induced muscle damage.</p></sec><sec id="sec2"><title>2. Material and Methods</title><sec id="sec2.1"><title>2.1. Study Design</title><p>In order to determine experimentally whether immune responses to exercise-induced inflammation are redox-sensitive, thiol-based antioxidant supplementation with NAC was utilized according to a cross-over, double-blind, repeated measures design employed in this study. NAC or placebo was administered daily during an 8-day recovery after an acute intense eccentric exercise protocol as previously published [<xref rid="B3" ref-type="bibr">3</xref>]. In between trials (NAC and placebo), a 6-week washout phase was utilized. Six weeks have been shown to be adequate for resolution of the inflammatory response induced by this type of eccentric exercise protocol [<xref rid="B3" ref-type="bibr">3</xref>]. NAC and placebo trials were administered in a random order for each participant. Prior to each trial, participants had their body weight, height, composition, and cardiovascular conditioning (maximal oxygen consumption, VO<sub>2max</sub>) measured. Blood sampling took place at baseline, immediately after exercise, 2&#x02009;h after exercise, and daily for eight consecutive days thereafter. Performance (leg strength) and muscle damage markers [delayed onset of muscle soreness (DOMS), knee joint range of motion (KJRM)] were measured at the same time points with blood sampling except immediately after exercise. Testing and blood sampling were administered always at the same time of day. Study's flowchart is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></sec><sec id="sec2.2"><title>2.2. Participants</title><p>Ten healthy male volunteers (age, 24.2 &#x000b1; 2.1&#x02009;yrs; weight, 78.5 &#x000b1; 7.8&#x02009;kg; height, 1.81 &#x000b1; 0.1&#x02009;m; body fat, 13.5 &#x000b1; 3.2%; VO<sub>2max</sub>, 49.2 &#x000b1; 5.1&#x02009;mL/kg/min) participated in this study. According to a preliminary power analysis, a sample of 10 participants was necessary to identify noteworthy statistical trial effects among serial measurements following a muscle-damaging protocol at a level of 0.90. Participants' inclusion in the study was decided if (a) they had a VO<sub>2max</sub> &#x0003e; 45&#x02009;mL/kg/min, (b) exercised regularly for &#x02265;3 times/week during the last 12 months prior to the study, (c) were nonsmokers, (d) abstained from exercise during the course of the two trials, and (e) did not consume performance-enhancing substances, antioxidants, caffeine, alcohol, and/or medications. Participants were excluded from the study if they had (a) a NAC intolerance and (b) recent musculoskeletal injuries of the lower limbs, febrile illness, and history of muscle lesion. Initially, 22 males were approached and 15 agreed to participate in this investigation. Four volunteers were excluded because they did not fulfil the selection criteria. All subjects provided a signed informed consent form and all experimental procedures were in accordance with the Helsinki Declaration for the ethical treatment of human subjects. Ethics approval was granted by the Institutional Review Board and Ethics Committee.</p></sec><sec id="sec2.3"><title>2.3. Exercise Protocol</title><p>The exercise protocol included 300 eccentric unilateral repetitions (performed in 20 sets of 15 repetitions/set with a 30 sec rest interval between sets) of knee extensors at a velocity of 30&#x000b0;/sec on an isokinetic dynamometer (Isoforce, TUR Gmbh, Berlin, Germany) as previously published [<xref rid="B4" ref-type="bibr">4</xref>]. This protocol has been documented by electron microscopy, biochemistry, and immunohistochemistry to cause extensive microtrauma of muscle fibers of the vastus lateralis [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>].</p></sec><sec id="sec2.4"><title>2.4. Supplementation Protocol</title><p>NAC was ingested orally at a dose of 20&#x02009;mg NAC/kg/day (Uni-Pharma) in three dosages. Supplementation started immediately after exercise and continued for eight consecutive days thereafter. The supplementation protocol has been described in detail elsewhere [<xref rid="B3" ref-type="bibr">3</xref>]. Briefly, NAC was dissolved in water, a sugar-free cordial, and a glucose/dextrose powder. Placebo had the same taste and appearance with NAC. This NAC supplementation protocol has been shown to increase muscle GSH and alter GSH/GSSG ratio [<xref rid="B3" ref-type="bibr">3</xref>].</p></sec><sec id="sec2.5"><title>2.5. Diet Monitoring and Measurement of Anthropometrics, Cardiovascular Conditioning Skeletal Muscle Performance, and Muscle Damage Markers</title><p>Nutritional intake was monitored prior to the first trial using a 7-day diet recall. Diet was also monitored daily during the first trial (1 recall per day). Accordingly, participants were asked to use exactly the same diet before and during the second trial. A registered dietitian trained participants how to complete the diet recalls and records were analyzed with Science Fit Diet 200A (Science Technologies). Body mass and height were measured and body mass index was calculated as previously described [<xref rid="B3" ref-type="bibr">3</xref>]. Participants' body composition was measured by Dual Emission X-ray Absorptiometry (DXA) as previously published [<xref rid="B34" ref-type="bibr">34</xref>]. VO<sub>2max</sub> was measured with a gas exchange analyzer (Oxycon Mobile, SensorMedics Corporation) during a graded exercise testing to exhaustion on a treadmill as previously described (Michailidis, 2013). Previous research has shown that cardiovascular and musculoskeletal conditioning level may affect skeletal muscle's antioxidant capacity and redox potential [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>]. Muscle performance (maximal knee extensor eccentric peak torque) was measured using an isokinetic dynamometer (Isoforce, TUR Gmbh, Berlin, Germany) at 60&#x000b0;/s as described [<xref rid="B4" ref-type="bibr">4</xref>]. The coefficient of variation (CV) for repeated measures was &#x0003c;4%. DOMS was assessed by palpation of the vastus medialis, vastus lateralis, and rectus femoris following a squat motion as previously published [<xref rid="B3" ref-type="bibr">3</xref>].</p></sec><sec id="sec2.6"><title>2.6. Blood Sampling and Assays</title><p>Blood samples (~16&#x02009;mL) were collected from an antecubital arm vein using a 20-gauge disposable needle with a Vacutainer holder while participants were seated following overnight fasting. Participants refrained from any strenuous physical activity, smoking, and alcohol consumption throughout the experimental period. A blood portion was collected into tubes with ethylenediaminetetraacetic acid (EDTA) that was immediately used for plasma preparation by centrifugation (at 1370&#x02009;g, 4&#x000b0;C, 15&#x02009;min) for the measurement of protein carbonyls (PC) and adhesion molecules. Another blood portion was collected into tubes with SST-Gel/clot activator, remained at room temperature for 30&#x02009;min to clot, and then was used for serum preparation by centrifugation (1500&#x02009;g, 4&#x000b0;C, 20&#x02009;min) for the measurement of cytokines, C-reactive protein (CRP), total antioxidant capacity (TAC), and creatine kinase activity (CK). Subsequently, packed red blood cells were collected following disruption of plasma samples according to procedures previously described [<xref rid="B37" ref-type="bibr">37</xref>] and the lysates were utilized for the measurement of the concentration of GSH, GSSG, thiobarbituric acid-reactive substances (TBARS), and catalase activity (CAT). Erythrocyte lysates as well as plasma and serum samples were stored at &#x02212;80&#x000b0;C in multiple aliquots. Another blood portion (2 mL) was collected in EDTA tubes for the assessment of a complete leukocyte count, hematocrit, and hemoglobin on an automated haematology analyser (coulter Beckman LH 750 analyzer, Fullerton, CA, USA) within 2 hours. Light exposure and autooxidation of blood samples were prevented. Samples were analyzed in duplicate.</p><p>An enzymatic assay was utilized to measure CK on a Clinical Chemistry Analyzer Z 1145 (Zafiropoulos Diagnostica, Athens, Greece) with a reagent kit (Zafiropoulos P., Greece). CRP and adhesion molecules were measured 2&#x02009;h after exercise and daily until day 3 of recovery. CRP was assayed using particle-enhanced immunonephelometry (Dade-Behring BN Prospec nephelometer). A multiplex assay kit (Linco, MO, USA) was used to measure the concentration of adhesion molecule sVCAM-1 and sICAM-1 on a Luminex-100 IS (Luminex, USA) as described [<xref rid="B38" ref-type="bibr">38</xref>]. Cytokines IL-1b and IL-6 were measured at 2&#x02009;h after exercise as well as on days 1, 2, 3, and 8 of recovery using a multiple analyte profiling assay (MILLIPLEX Human Cytokine Panel, Millipore Corp) on a Luminex-100 IS Integrated System (Luminex Corporation). GSH was measured spectrophotometrically at 412&#x02009;nm in TCA-treated erythrocyte lysates as previously published [<xref rid="B39" ref-type="bibr">39</xref>]. For the measurement of GSSG, TCA-treated erythrocyte lysates and samples were measured spectrophotometrically at 412&#x02009;nm for 3&#x02009;min following procedures as previously described [<xref rid="B39" ref-type="bibr">39</xref>]. Calibration curves were constructed for the calculation of GSH and GSSG concentration. TBARS was measured spectrophotometrically (530&#x02009;nm) as a marker of lipid peroxidation in TCA-treated erythrocyte lysates following addition of thiobarbituric acid as described [<xref rid="B39" ref-type="bibr">39</xref>]. PC were assayed spectrophotometrically (375&#x02009;nm) as an index of protein oxidation in TCA-treated erythrocyte lysates following addition of 2,4-dinitrophenylhydrazine, ethanol&#x02013;ethyl acetate and urea as described [<xref rid="B39" ref-type="bibr">39</xref>]. TAC was measured spectrophotometrically (520&#x02009;nm) in serum treated with sodium&#x02013;potassium phosphate and 2,2-diphenyl-1 picrylhydrazyl as described [<xref rid="B39" ref-type="bibr">39</xref>]. Spectrophotometric analyses were performed using a Hitachi 2001 UV/VIS (Hitachi Instruments Inc., US) instrument. Inter- and intra-assay CVs for all assays were 2.5&#x02013;7.3% and 3.7&#x02013;8.2%, respectively.</p><p>Blood samples for flow cytometry were collected into EDTA-coated vacutainer tubes and preserved at room temperature until processed. For isolation of peripheral mononuclear cells (PBMCs), blood samples underwent density gradient centrifugation (400&#x02009;g, 30&#x02009;min, room temperature) using Ficoll-paque (Amersham, Uppsala, Sweden) in 15 mL conical tubes. PBMCs were then transferred into a 50&#x02009;mL conical tube and washed twice with 50&#x02009;mL of phosphate-buffered salt solution (PBS). Cell number and viability were checked using the trypan blue exclusion test on an improved Neubauer chamber (PRECICOLOR HBG, Germany). Cells were then frozen in freezing solution containing fetal calf serum (FCS) and DMSO (the ratio FCS/DMSO was 1&#x02009;:&#x02009;10). Samples were kept at &#x02212;80&#x000b0;C until various subsets of leukocytes were analyzed by flow cytometry. Prior to analysis by flow cytometry, cells were thawed from &#x02212;80&#x000b0;C using a 37&#x000b0;C water bath and centrifuged (1,800&#x02009;rpm, 10&#x02009;min, room temperature) twice in 50&#x02009;mL washing buffer (PBS). Cytofluorometric analysis was performed as previously described [<xref rid="B40" ref-type="bibr">40</xref>]. Briefly, samples (20&#x02009;<italic>&#x003bc;</italic>L) were allocated in tubes containing 100&#x02009;<italic>&#x003bc;</italic>L PBS and incubated with a 10 <italic>&#x003bc;</italic>L antibody solution specific for CD3 FITC-anti-mouse, CD4 PerCP-Cy5,5-anti mouse, CD8 PE-anti mouse, CD14 FITC-anti mouse and CD 14 PEanti mouse, HLA-DR FITC anti-mouse, CD11b PerCP-Cy5,5-anti mouse, CD19 PE-anti mouse, CD45 PerCP-Cy5,5-anti mouse, CD56 PerCP-Cy5,5-anti mouse, and CD62L FITC anti-mouse (all from BD Pharmingen, SanDiego, CA, USA) in the dark for 30&#x02009;min. Controls used were mouse anti-human IgG isotypes for FITC, PE, and PerCP-Cy5,5. Antigens detected on lymphocytes and monocytes in peripheral blood are shown in <xref ref-type="table" rid="tab1">Table 1</xref>. Samples were then fixed with 400&#x02009;<italic>&#x003bc;</italic>L of 1x CellFix solution (BD Pharmingen). Cells underwent a cytofluorometric analysis on a three-colour fluorescence FACSCalibur cytometer and CellQuest software (Becton-Dickinson, San Jose, CA, USA) using laser extinction at 585&#x02009;nm (phycoerythrin), 530&#x02009;nm (fluorescein isothiocyanate), and Cy-chrome/PerCP-Cy5.5 695&#x02009;nm. Cells were detected and electronically gated using forward light-scatter and side light-scatter modes as described [<xref rid="B40" ref-type="bibr">40</xref>]. Approximately, 10,000 gated events per condition were analyzed using a standardized gating technique and procedure as described [<xref rid="B40" ref-type="bibr">40</xref>]. Values obtained for lymphocyte and monocyte subpopulations represent the percentage of each subset within the overall population of lymphocytes and monocytes, respectively. All samples from a single subject were analyzed in a single run. The typical error of measurement ranged between 2.51% and 4.2%.</p></sec><sec id="sec2.7"><title>2.7. Statistical Analysis</title><p>Data are presented as means &#x000b1; SD. Normality was assessed using a Kolmogorov&#x02013;Smirnov test. A repeated measures ANOVA [trial (placebo and NAC) &#x000d7; time (baseline, after exercise, 2&#x02009;h after exercise, and 1, 2, 3, 4, 5, 6, 7, and 8&#x02009;d after exercise or 2&#x02009;h after exercise, and 1, 2, and 3&#x02009;d for some inflammatory markers and 2&#x02009;h after exercise, and 1, 2, and 3&#x02009;d for cytokines)]. A Bonferonni post hoc test was utilized to determine potential treatment effects. A repeated measures ANOVA (on time) was used to determine potential differences in dependent variables between trials at baseline. Significance was accepted at <italic>P</italic> &#x0003c; 0.05. SPSS software for Windows was used for all statistical analyses (SPSS Inc., Chicago, IL, USA).</p></sec></sec><sec id="sec3"><title>3. Results</title><p>No differences were detected in subjects' body mass, body composition, daily nutrient intake (<xref ref-type="table" rid="tab1">Table 1</xref>), VO<sub>2max</sub>, and leg strength at baseline before each trial. No side effects to NAC consumption were reported by the subjects.</p><sec id="sec3.1"><title>3.1. Redox Status Changes</title><p>GSH (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>) in PLA was reduced (<italic>P</italic> = 0.000&#x02013;0.003) immediately after exercise and normalized on day 6 whereas, in NAC, it decreased (<italic>P</italic> = 0.000&#x02013;0.003) immediately after exercise and normalized on day 5. GSH was maintained 4&#x02013;16% (<italic>P</italic> = 0.000) higher in NAC compared to PLA throughout recovery (except immediately after exercise). GSSG (<xref ref-type="fig" rid="fig2">Figure 2(b)</xref>) increased in PLA immediately after exercise, peaked at 72&#x02009;h after exercise, remained elevated until day 6 of recovery (3&#x02013;26%; <italic>P</italic> = 0.000&#x02013;0.004), and normalized thereafter whereas in NAC it increased after exercise, peaked at 48&#x02009;h, remained elevated until day 3 of recovery (3&#x02013;14.5%; <italic>P</italic> = 0.000&#x02013;0.019), normalized on days 4 through 6, and declined on day 8 (9%; <italic>P</italic> = 0.000). However, no differences were detected between trials. GSH/GSSG ratio (<xref ref-type="fig" rid="fig2">Figure 2(c)</xref>) in PLA declined until day 6 of recovery (9&#x02013;43.5%, <italic>P</italic> = 0.000&#x02013;0.009), reached its nadir at 48&#x02009;h, and normalized on days 7 and 8 of recovery whereas in NAC it declined until day 4 (8&#x02013;26%; <italic>P</italic> = 0.000), reached its nadir at 48&#x02009;h, normalized on day 5, and increased (10&#x02013;30%; <italic>P</italic> = 0.000) on days 6 through 8 of recovery. NAC exhibited a smaller decline of GSH/GSSG ratio on days 2 through 5 (<italic>P</italic> = 0.000&#x02013;0.048) and a greater rise on days 6 through 8 (<italic>P</italic> = 0.000) than PLA. TAC (<xref ref-type="fig" rid="fig2">Figure 2(d)</xref>) increased similarly in both trials (PLA: ~17%&#x02013;41%, <italic>P</italic> = 0.000&#x02013;0.04; NAC: ~15%&#x02013;45%, <italic>P</italic> = 0.000&#x02013;0.02) until day 5 of recovery, peaked on day 3 in both trials, and normalized thereafter. PC (<xref ref-type="fig" rid="fig2">Figure 2(e)</xref>) in PLA increased at 2&#x02009;h and remained elevated throughout recovery, demonstrating a peak on day 3 (11&#x02013;96%, <italic>P</italic> = 0.000&#x02013;0.01). PC in NAC increased at 2&#x02009;h and remained elevated until day 6, demonstrating a peak on day 3 (23&#x02013;67%, <italic>P</italic> = 0.000&#x02013;0.06). PC remained higher (<italic>P</italic> = 0.002&#x02013;0.033) in PLA than NAC in days 1 through 6 of recovery. TBARS (<xref ref-type="fig" rid="fig2">Figure 2(f)</xref>) in PLA increased at 2&#x02009;h and remained elevated until day 5 of recovery, demonstrating a peak on day 3 (22&#x02013;59%, <italic>P</italic> = 0.000&#x02013;0.008) whereas in NAC it increased at 2&#x02009;h and remained elevated until day 4 of recovery, demonstrating a peak on day 3 (16&#x02013;44%, <italic>P</italic> = 0.000). NAC exhibited lower TBARS levels than PLA on days 2 (<italic>P</italic> = 0.08), 3 (<italic>P</italic> = 0.05), and 6 (<italic>P</italic> = 0.091).</p></sec><sec id="sec3.2"><title>3.2. Changes in Muscle Performance and Muscle Damage Markers</title><p>Mean relative (Nm/Kg) eccentric peak torque (<xref ref-type="fig" rid="fig3">Figure 3(a)</xref>) declined in both trials (PLA: ~5%&#x02013;53%, <italic>P</italic> = 0.000; NAC: ~4.5%&#x02013;43%, <italic>P</italic> = 0.000) 2&#x02009;h after exercise and during the first six days of recovery reaching both a nadir value on day 2 of recovery. The performance decline in NAC was less pronounced than that observed in PLA during days 1 through 3 of recovery (<italic>P</italic> = 0.001). DOMS (<xref ref-type="fig" rid="fig3">Figure 3(b)</xref>) declined in both trials during the first seven days of recovery (PLA: ~1.9&#x02013;9.9-fold, <italic>P</italic> = 0.000&#x02013;0.009; NAC: ~1.8&#x02013;9.3-fold, <italic>P</italic> = 0.000&#x02013;0.029) reaching its highest value on day 2 for both treatments. PLA induced a greater rise in DOMS than NAC on days 2 (<italic>P</italic> = 0.004) and 3 (<italic>P</italic> = 0.002). CK (<xref ref-type="fig" rid="fig3">Figure 3(c)</xref>) in PLA increased at 2&#x02009;h after exercise (<italic>P</italic> = 0.000), remained elevated (<italic>P</italic> = 0.004&#x02013;0.039) until day 6 of recovery, and normalized thereafter, reaching its peak on day 3 (~4-fold, <italic>P</italic> = 0.003). CK in NAC increased 1&#x02009;d after exercise (<italic>P</italic> = 0.001), remained elevated (<italic>P</italic> = 0.021&#x02013;0.089) until day 4 of recovery, and normalized thereafter, reaching its peak on day 3 (~3-fold, <italic>P</italic> = 0.033). Post hoc analysis revealed no differences between trials throughout recovery.</p></sec><sec id="sec3.3"><title>3.3. Changes in Inflammatory Markers</title><p>CRP (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>) remained increased (<italic>P</italic> = 0.000) during the first two days of recovery and normalized thereafter in both trials. PLA demonstrated higher CRP values on days 1 (<italic>P</italic> = 0.002) and 2 (<italic>P</italic> = 0.003) of recovery. sICAM-1 (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>) increased at all time points in PLA (5.5%&#x02013;40%, <italic>P</italic> = 0.000&#x02013;0.001) whereas in NAC it decreased only at 2&#x02009;h after exercise (21%, <italic>P</italic> = 0.005). However, no differences in sICAM-1 changes were noted among trials. sVCAM-1 (<xref ref-type="fig" rid="fig4">Figure 4(c)</xref>) declined in both trials (PLA: 1&#x02013;2.2-fold, <italic>P</italic> = 0.000; NAC: 1&#x02013;2.1-fold, <italic>P</italic> = 0.000) at all time points measured during recovery with PLA inducing a greater rise (<italic>P</italic> = 0.016) than NAC on day 2 of recovery. IL-1b (<xref ref-type="fig" rid="fig4">Figure 4(d)</xref>) increased at 2&#x02009;h after exercise (3.9-fold, <italic>P</italic> = 0.002) and on day 1 (3.3-fold, <italic>P</italic> = 0.063) in PLA whereas in NAC it increased only at 2&#x02009;h after exercise (3.2-fold, <italic>P</italic> = 0.021). However, no differences were noted among trials. IL-6 (<xref ref-type="fig" rid="fig4">Figure 4(e)</xref>) increased similarly in both trials throughout recovery (PLA: ~15%&#x02013;23%, <italic>P</italic> = 0.000; NAC: ~13%&#x02013;18%, <italic>P</italic> = 0.000).</p></sec><sec id="sec3.4"><title>3.4. Immune System Responses</title><p>White blood cell count (WBC, <xref ref-type="fig" rid="fig5">Figure 5(a)</xref>) increased in both trials immediately after exercise (~20%, <italic>P</italic> = 0.000), peaked at 2&#x02009;h after exercise (PLA: ~47%, <italic>P</italic> = 0.000; NAC: ~25%, <italic>P</italic> = 0.000), remained elevated (PLA: ~11%, <italic>P</italic> = 0.000; NAC: ~10%, <italic>P</italic> = 0.008) 24&#x02009;h after exercise, and returned to baseline values thereafter. WBC rise was more pronounced (<italic>P</italic> = 0.02) in PLA than NAC at 2&#x02009;h after exercise. Neutrophil count (<xref ref-type="fig" rid="fig5">Figure 5(b)</xref>) increased in both trials after exercise (PLA: ~35%, <italic>P</italic> = 0.000; NAC: ~31%, <italic>P</italic> = 0.000), peaked at 2&#x02009;h of recovery (PLA: ~95%, <italic>P</italic> = 0.000; NAC: ~45%, <italic>P</italic> = 0.035), and normalized thereafter. PLA demonstrated a greater (<italic>P</italic> = 0.01) rise in neutrophil count than NAC at 2&#x02009;h after exercise. No time-dependent changes in lymphocyte (<xref ref-type="fig" rid="fig5">Figure 5(c)</xref>), monocyte (<xref ref-type="fig" rid="fig5">Figure 5(d)</xref>), and basophile (<xref ref-type="fig" rid="fig5">Figure 5(e)</xref>) counts were detected in both trials during exercise recovery. Eosinophil count (<xref ref-type="fig" rid="fig5">Figure 5(f)</xref>) decreased only (~46%, <italic>P</italic> = 0.011) in PLA at 2&#x02009;h after exercise.</p><p>T-helper cells (<xref ref-type="fig" rid="fig6">Figure 6(a)</xref>), T cytotoxic cells (<xref ref-type="fig" rid="fig6">Figure 6(b)</xref>), NK-T cells (<xref ref-type="fig" rid="fig6">Figure 6(c)</xref>), and 62L macrophages (<xref ref-type="fig" rid="fig6">Figure 6(d)</xref>) remained unchanged in both trials throughout recovery. B lympho cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>) increased only in PLA 2&#x02009;h after exercise (68%, <italic>P</italic> = 0.082). Natural killer cells (NK, <xref ref-type="fig" rid="fig8">Figure 8</xref>) declined only in PLA 2&#x02009;h after exercise (~36.5%, <italic>P</italic> = 0.018). When percent changes were compared, NK demonstrated a greater decline in PLA than NAC 2&#x02009;h after exercise (~36.5% in PLA versus ~12% in NAC, <italic>P</italic> = 0.09) as well as at 3&#x02009;d (~35% in PLA versus ~3% in NAC, <italic>P</italic> = 0.036), 5&#x02009;d (~35% in PLA versus ~19% in NAC, <italic>P</italic> = 0.062), and 7&#x02009;d (~42% in PLA versus ~14% in NAC, <italic>P</italic> = 0.039). Although macrophages (<xref ref-type="fig" rid="fig9">Figure 9</xref>) demonstrated no time-dependent changes in both trials, statistical analysis revealed that PLA induced a more pronounced rise than NAC 2&#x02009;h after exercise (~53% in PLA versus ~1% in NAC, <italic>P</italic> = 0.016). Likewise, HLA<sup>+</sup>/Macr<sup>+</sup> (<xref ref-type="fig" rid="fig10">Figure 10</xref>) and 11B+ macrophages (<xref ref-type="fig" rid="fig11">Figure 11</xref>) exhibited no time-dependent changes in both groups throughout recovery but statistical analysis revealed that PLA demonstrated a greater increase than NAC 2&#x02009;h after exercise (HLA<sup>+</sup>/Macr<sup>+</sup>: ~75% in PLA versus ~48% in NAC, <italic>P</italic> = 0.027; 11B+: ~66.5% in PLA versus ~39.5% in NAC, <italic>P</italic> = 0.025).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>The present investigation provides evidence that mobilisation of leukocytes in response to exercise-induced inflammation induced by very intense exercise may be redox dependent. These results verify previous observations of a redox-sensitive regulation of exercise-induced inflammation and muscle performance [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B41" ref-type="bibr">41</xref>].</p><p>NAC ingestion protocols similar to ours have been shown to increase NAC bioavailability in the circulation [<xref rid="B42" ref-type="bibr">42</xref>] probably due to a reduction of its clearance from the circulation during exercise [<xref rid="B43" ref-type="bibr">43</xref>]. As previously shown under conditions of elevated oxidative stress [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>], NAC reduced (4&#x02013;16%) the decline of GSH during the first five days of recovery and maintained it at a higher level than PLA on days 6&#x02013;8 of recovery (~10&#x02013;15%). Similar responses of erythrocyte GSH have been reported under in vivo and in vitro conditions [<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>]. It appears that NAC supplementation does not affect GSH resynthesis from GSSG but it rather upregulates GSH availability thereby altering GSH/GSSG due to a rise in intracellular cysteine concentration due to its increased active transport from extracellular space using the g-glutamyl cycle, at least in muscle and erythrocytes [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B45" ref-type="bibr">45</xref>&#x02013;<xref rid="B48" ref-type="bibr">48</xref>]. A single oral bolus of 600&#x02009;mg NAC to humans raises free reduced NAC concentration in plasma at ~2.5&#x02013;4.6&#x02009;uM within 60&#x02013;90&#x02009;min verifying the relatively fast uptake of NAC by blood cells such as the 60-minute uptake by erythrocytes [<xref rid="B46" ref-type="bibr">46</xref>] and implies that NAC effects on these cells are mediated mostly intracellularly rather than by an upregulation of extracellular antioxidant environment [<xref rid="B49" ref-type="bibr">49</xref>]. These findings are in agreement with the GSH rise seen within the first 2&#x02009;h after exercise in this study.</p><p>Under stress, NAC consumption may not affect total GSH levels but rather causes an attenuation of GSH decline because it increases free sulfhydryl groups in the circulation [<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B50" ref-type="bibr">50</xref>&#x02013;<xref rid="B52" ref-type="bibr">52</xref>] resulting in an upregulation of intracellular NAC levels and free cysteine residues by rapid deacetylation which then elevate intracellular GSH and alter GSH/GSSG [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B53" ref-type="bibr">53</xref>]. ROS scavengers may promote GSH sparing and thus lessen GSH depletion and GSH/GSSG reduction (redox status) intracellularly as seen in muscle, erythrocytes, and leukocytes [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B54" ref-type="bibr">54</xref>]. Postexercise GSH sparing and accelerated normalization of redox status in response to NAC ingestion has also been observed extracellularly, that is, in the circulation [<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>]. GSH may further contribute to the attenuation of GSH/GSSG decline and the blunted elevation of oxidative stress markers (i.e., TBARS, PC) via the glutathione peroxidase reaction that mediates H<sub>2</sub>O<sub>2</sub> clearance [<xref rid="B35" ref-type="bibr">35</xref>]. NAC administration not only accelerates the normalization of GSH and GSH/GSSH after exercise but also mitigates muscle performance drop during recovery, as in this study [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B57" ref-type="bibr">57</xref>]. NAC may also enhance the GSH-dependent estrogenic activity which contributes to induction of genes encoding enzymatic proteins regulating GSH turnover such as GSH reductase [<xref rid="B58" ref-type="bibr">58</xref>]. Redox changes may regulate redox-sensitive intracellular signaling pathways that control cellular phenotype under stress [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B41" ref-type="bibr">41</xref>]. However, at basal state, when oxidative stress is normalized, NAC ingestion may not alter oxidative stress markers despite a rise in GSH and GSH/GSSG [<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>] as shown in days 5&#x02013;8 of postexercise recovery in this study.</p><p>The eccentric exercise protocol used in this study has been shown to cause a marked skeletal muscle damage as documented by both histochemical and biochemical data [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. The pronounced rise of CK after exercise was accompanied by an intense acute inflammatory response (marked rise of WBC, CRP, cytokines, and adhesion molecules) and a substantial decline of muscle performance in both trials. The reduced muscle damage response in NAC may be further explained by previous observations of attenuated eccentric exercise-induced muscle injury following neutrophil and macrophage depletion suggesting that neutrophil's/macrophages' oxidative burst may be responsible for part of muscle's injury during early recovery [<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B61" ref-type="bibr">61</xref>]. Therefore, the blunted rise of neutrophils in NAC may partly explain the attenuated muscle damage (blunted CK and CRP rise). Muscle function was better protected by NAC during that period, an effect reported by previous studies [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>]. This protective effect of NC may be related to GSH enhancement. GSH deficiency has been shown to impair muscle function [<xref rid="B56" ref-type="bibr">56</xref>]. NAC may be able to maintain the activity of Na+/K+ pump in muscle due to a redox-dependent [<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>] attenuation of sarcoplasmic reticulum injury [<xref rid="B11" ref-type="bibr">11</xref>] that results in a lower calcium release and thus a reduced activity of muscle's proteolytic proteins such as the proteosome and calpains [<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B67" ref-type="bibr">67</xref>].</p><sec id="sec4.1"><title>4.1. Neutrophil Responses</title><p>Exercise-induced muscle injury triggers a pronounced immune response which is expressed as an early (&#x02264;24&#x02009;h) mobilization and infiltration of neutrophils into traumatized tissue, followed by a later activation and entry of macrophages [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. This immune mobilization was also observed in this study. The rise in neutrophil count in peripheral blood is caused by exercise-induced demargination [<xref rid="B62" ref-type="bibr">62</xref>]. When neutrophils reach the injured tissue using a process called margination, they remove cellular debris using phagocytosis and discharge proteolytic enzymes and ROS into the extracellular space and into the phagosome [<xref rid="B11" ref-type="bibr">11</xref>]. ROS release is achieved through a process known as respiratory burst during which activated neutrophils and other phagocytes generate increased numbers of superoxide anions which then are converted to powerful oxidants (i.e., H<sub>2</sub>O<sub>2</sub> and hypochloride) [<xref rid="B68" ref-type="bibr">68</xref>]. This process may cause secondary damage to healthy neighboring tissues [<xref rid="B68" ref-type="bibr">68</xref>]. A decline in respiratory burst has also been seen in healthy volunteers following a 14&#x02009;d NAC ingestion [<xref rid="B49" ref-type="bibr">49</xref>]. NAC-induced attenuation of neutrophils' oxidative burst has been consistently seen in animal tissues as well [<xref rid="B69" ref-type="bibr">69</xref>] and it may be attributed to a reduction of myeloperoxidase activity (MPO) [<xref rid="B70" ref-type="bibr">70</xref>] and/or cellular ATP [<xref rid="B49" ref-type="bibr">49</xref>]. A reduction of MPO could be explained by a direct scavenging action by NAC on ROS produced by MPO, or by noncompetitive mechanism by binding to MPO or even by competitive inhibition at or near the active site of the enzyme by GSH [<xref rid="B71" ref-type="bibr">71</xref>]. The NAC-related decline of cellular ATP may be associated with an inhibition of sodium ions due to altered activity of sodium channels independent of an effect on Na+&#x02013;K+-ATPase activity and K+ conductance resulting in increased levels of sodium intracellularly and leakage of potassium ions into the extracellular space [<xref rid="B72" ref-type="bibr">72</xref>]. This ion exchange results in entry of water into the cell, expansion of endoplasmic reticulum, and injury to ribosomes that stops protein synthesis [<xref rid="B72" ref-type="bibr">72</xref>].</p><p>The rise of WBC and neutrophil count was attenuated by NAC administration during the first postexercise hours. Although not statistically significant, it is physiologically interesting that neutrophils remained more elevated (~12%) in PLA compared to NAC 1&#x02009;d after exercise. In contrast with our results, GSH and NAC supplementation in rats augmented neutrophil mobilization and respiratory burst and reduced leukocyte margination suggesting a thiol-induced upregulation of neutrophils after exercise [<xref rid="B62" ref-type="bibr">62</xref>]. However, the majority of human, animal, and in vitro studies are in agreement with results of this study. Supplementation with sulfur-containing amino acids (cysteine, theanine) also led to increased GSH and an attenuated neutrophilic response to very intense exercise [<xref rid="B73" ref-type="bibr">73</xref>]. Similarly, pretreatment of patients with chronic obstructive pulmonary disease with NAC upregulated thiol levels and effectively reduced neutrophil chemotaxis and ROS [<xref rid="B29" ref-type="bibr">29</xref>]. Similarly, high dosages (0.6&#x02013;1.0&#x02009;g) of NAC administered orally three times daily for 4 weeks to patients with cystic fibrosis increased neutrophil GSH levels and reduced airway inflammation (neutrophil migration in airways, elastase activity, and IL-8 levels) [<xref rid="B71" ref-type="bibr">71</xref>]. NAC administration to older females, neutrophil function (adherence, chemotaxis, phagocytosis, and oxidative burst), and oxidative stress were normalized and approached values of younger females further supporting a redox-dependent regulation of neutrophil function [<xref rid="B54" ref-type="bibr">54</xref>]. NAC infusion to rats with sepsis resulted in reduced oxidative stress, neutrophil density, and IL-1b [<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B74" ref-type="bibr">74</xref>]. Similarly, neutrophil function was inhibited by a 3% NAC solution in mares and mitigated the ROS-mediated injury to the endometrial epithelium and sperm by attenuating neutrophils' oxidative burst [<xref rid="B69" ref-type="bibr">69</xref>].</p><p>NAC's antineutrophilic action may be mediated by several mechanisms. NAC-induced changes in redox status seem to blunt the rise of proinflammatory cytokines such as IL-1b, IL-6, and IL-8 as seen in this study [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B74" ref-type="bibr">74</xref>] probably due to an inhibition of their gene expression and/or protein synthesis [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B32" ref-type="bibr">32</xref>]. Synthesis and release of proinflammatory cytokines are directly or indirectly dependent on NF-kB phosphorylation and p38MAPK activation which are also under redox-sensitive regulation and are subjected to downregulation by NAC for several days after exercise [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. NAC-induced suppression of proinflammatory cytokines may result in compromised neutrophil survival. Neutrophilia observed during early inflammation is terminated by neutrophil apoptosis and their removal by macrophages in an attempt to minimize oxidative damage. This process is however delayed by proinflammatory chemokines and cytokines [<xref rid="B75" ref-type="bibr">75</xref>] and thus prevent engulfment of neutrophils by macrophages [<xref rid="B76" ref-type="bibr">76</xref>]. NAC on the other hand may promote neutrophil apoptosis and removal by increasing neutrophil GSH thereby leading to altered redox status and reduction of expression and release of proinflammatory cytokines such as IL-1b and TNF<italic>&#x003b1;</italic> [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B74" ref-type="bibr">74</xref>] as well as by promoting chemotaxis of phagocytes [<xref rid="B54" ref-type="bibr">54</xref>].</p><p>A NAC-related blunted rise of proinflammatory cytokines may also affect neutrophil migration and extravasation [<xref rid="B77" ref-type="bibr">77</xref>]. For example, sICAM-1, an adhesion molecule mediating neutrophil transmigration, is downregulated due to NAC-induced inhibition of TNF-a, IL-1b, and IL-8 expression [<xref rid="B78" ref-type="bibr">78</xref>]. Inhibited neutrophil migration may also result in a NAC-related decline in IL-8 dependent elastase release by neutrophils [<xref rid="B79" ref-type="bibr">79</xref>] and facilitate the downregulation of molecules released by the endothelial epithelial bilayer that promote neutrophil migration [<xref rid="B49" ref-type="bibr">49</xref>]. For instance, inhibition of redox-dependent MAPK signaling by NAC [<xref rid="B3" ref-type="bibr">3</xref>] disrupts LTB4 signaling that facilitates transepithelial migration via a redox-dependent interaction of adhesion molecules with neutrophils and proteins [<xref rid="B80" ref-type="bibr">80</xref>]. NAC has also been shown to inhibit sVCAM-1 expression by downregulating NF-<italic>&#x003ba;</italic>B binding to its gene motif and thus reducing neutrophils' adhesion to endothelium and migration into the affected tissue [<xref rid="B81" ref-type="bibr">81</xref>]. In fact, sICAM-1 and sVCAM-1 in NAC demonstrated a blunted response to exercise in this study. These results indicate a redox-dependent control of neutrophils' kinetics and function in response to exercise-induced injury.</p></sec><sec id="sec4.2"><title>4.2. Macrophage Responses</title><p>Phagocytic macrophages infiltrate the endomysium and perimysium of injured skeletal muscle after neutrophil invasion reaching a peak 1&#x02009;d after exercise and remain elevated for ~2&#x02013;4&#x02009;d depending on the magnitude of the insult [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B9" ref-type="bibr">9</xref>]. Macrophages of M1 phenotype are proinflammatory and contribute to propagation of inflammation by producing cytotoxic nitric oxide and thus inducing further muscle damage [<xref rid="B1" ref-type="bibr">1</xref>]. M1 macrophages, after their peak, are usually replaced by M2 macrophages that promote resolution of inflammation and repair of injured tissue [<xref rid="B1" ref-type="bibr">1</xref>]. In this study, although statistically nonsignificant, an increase was observed in total macrophages (4&#x02013;53% in PLA, 1&#x02013;14% in NAC) as well as in HLA<sup>+</sup>/Macr<sup>+</sup> (4&#x02013;75% in PLA, 8&#x02013;53% in NAC) and 11B+ macrophages (up to 66% in PLA, up to 70% in NAC) during recovery.</p><p>Michailidis et al. [<xref rid="B3" ref-type="bibr">3</xref>] reported a dampened response for 68<sup>+</sup> macrophage infiltration in injured muscle using the same exercise protocol. Similarly, our results revealed that total macrophages (~53% in PLA versus ~1% in NAC), HLA<sup>+</sup>/Macr<sup>+</sup> (75% in PLA versus 48% in NAC), and 11B<sup>+</sup> (66% in PLA versus 40% in NAC) response to exercise was attenuated in NAC compared to PLA at 2&#x02009;h after exercise. Although data from exercise studies is scarce, attenuation of macrophage response has been shown by in vivo and in vitro nonexercise studies. NAC appears to increase intracellular GSH and alter redox status of macrophages [<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>]. NAC ingestion to humans caused a marked reduction in macrophage number as well as in IL-1b and IL-6 concentration during an ischemia-reperfusion model [<xref rid="B74" ref-type="bibr">74</xref>]. Furthermore, in ApoE<sup>&#x02212;/&#x02212;</sup> mice, NAC consumption reduced ROS production, VCAM-1 synthesis, and accumulation of macrophages in atherosclerotic plaque [<xref rid="B84" ref-type="bibr">84</xref>]. In vitro results revealed that NAC administration resulted in a redox-dependent reduction in macrophage survival [<xref rid="B85" ref-type="bibr">85</xref>] and PBMC proliferation [<xref rid="B86" ref-type="bibr">86</xref>].</p><p>ROS generation by the NADPH oxidase complex is probably required for macrophage survival since inhibition of this process leads to reduced survival rates in a redox-dependent manner and is associated with an attenuation of Akt and p38 MAPK signaling [<xref rid="B85" ref-type="bibr">85</xref>]. NAC consumption during eccentric exercise-induced inflammation has been shown to attenuate both Akt/mTOR and p38 MAPK signaling [<xref rid="B3" ref-type="bibr">3</xref>]. According to Geudens et al. [<xref rid="B74" ref-type="bibr">74</xref>], IL-6 produced by immune cells in response to IL-1b activation may exert a pleiotropic action by further increasing macrophage mobilisation under inflammatory load, a response that is consistently blunted by NAC under such conditions [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B86" ref-type="bibr">86</xref>]. This attenuation of cytokine response by NAC may occur at posttranscriptional level [<xref rid="B32" ref-type="bibr">32</xref>] and is NF-<italic>&#x003ba;</italic>B-dependent [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B84" ref-type="bibr">84</xref>]. Others suggested that NAC at high dosages may promote phagocytosis and intracellular killing in alveolar macrophages indicating that NAC may induce self-killing of macrophages [<xref rid="B87" ref-type="bibr">87</xref>]. Furthermore, NAC may interfere with adherence and chemotaxis of macrophages under inflammatory conditions [<xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B84" ref-type="bibr">84</xref>]. Collectively, these finding suggest that macrophage mobilisation under inflammatory conditions induced by exercise-induced microtrauma may be redox-dependent.</p></sec><sec id="sec4.3"><title>4.3. Lymphocytes' Responses</title><p>Although lymphocyte count, T-helper cells, T cytotoxic cells, and NK-T cells remained unaffected by exercise in both trials, B lympho cells (a lymphocyte subtype that expresses clonally diverse cell surface immunoglobulin receptors recognizing specific antigenic epitopes) increased only in PLA 2&#x02009;h after exercise and natural killer (NK) cells declined only in PLA 2&#x02009;h after exercise. Intense exercise-induced lymphocytopenia and immunosuppression is a well-described phenomenon [<xref rid="B88" ref-type="bibr">88</xref>]. High-intensity running results in a considerable apoptosis of lymphocytes within 24&#x02009;h of recovery [<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>]. In line with our results, Nielsen et al. [<xref rid="B90" ref-type="bibr">90</xref>] also demonstrated a reduction of NK cell activity and proliferation within 2&#x02009;h of exercise recovery [<xref rid="B90" ref-type="bibr">90</xref>]. This exercise-induced reduction of NK may be attributed to ROS that increase peroxidation levels of lipids located in their membranes [<xref rid="B91" ref-type="bibr">91</xref>, <xref rid="B92" ref-type="bibr">92</xref>]. Similarly, Petersen et al. [<xref rid="B41" ref-type="bibr">41</xref>] showed that intense exercise results in a fall of lymphocyte levels during recovery. Exercise-induced lymphocytopenia (~40% reduction in lymphocyte levels within the first 24&#x02009;h of exercise recovery) may be attributed to increased apoptosis due to mitochondrial membrane depolarization, increased ROS, and a decline in intracellular GSH [<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B93" ref-type="bibr">93</xref>]. Intense prolonged running has been shown to elicit DNA base oxidation in human leukocytes that was correlated with lipid hydroperoxides levels in the circulation [<xref rid="B94" ref-type="bibr">94</xref>]. Moreover, increased blood isoprostanes may be adequate to promote lymphocyte apoptosis [<xref rid="B89" ref-type="bibr">89</xref>, <xref rid="B95" ref-type="bibr">95</xref>]. This is further supported by observations of reduced lymphocyte DNA fragmentation by antioxidant supplementation [<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>] which is in line with our findings of an abolishment of lymphocyte fall after exercise in NAC.</p><p>Supplementation with sulfur-containing amino acids (cysteine, theanine) also attenuated exercise-induced lymphocytopenia [<xref rid="B73" ref-type="bibr">73</xref>]. GSH upregulation may inhibit, at least partially, lymphocyte membrane depolarization and DNA oxidation [<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B99" ref-type="bibr">99</xref>]. In fact, GSH-depleted thymocytes were more susceptible to apoptosis [<xref rid="B100" ref-type="bibr">100</xref>] whereas NAC appears to inhibit GSH depletion and enhance lymphocyte survival [<xref rid="B88" ref-type="bibr">88</xref>]. Furthermore, NAC reduced lymphocyte apoptosis due to exposure to oxidative stress related apoptotic insults (glucocorticoids, H<sub>2</sub>O<sub>2</sub>, Fas, and TCR signaling) [<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B102" ref-type="bibr">102</xref>]. In fact, NAC appears to reduce lymphocyte apoptosis through a mitigation of the rise of proapoptotic proteins (caspase 3 and cytosolic cytochrome c) and an elevation of antiapoptotic proteins (Bcl-2) after exercise [<xref rid="B33" ref-type="bibr">33</xref>].</p><p>Apoptotic lymphocytes seem to express elevated levels of Fas and FasL 24&#x02009;h after heavy physical exertion [<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B103" ref-type="bibr">103</xref>]. NF-<italic>&#x003ba;</italic>B that mediates the communication between ROS and Fas signaling is activated and transported into the nucleus rapidly in response to exercise-induced muscle injury and induces the synthesis of proinflammatory cytokines [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B104" ref-type="bibr">104</xref>]. NF-<italic>&#x003ba;</italic>B downregulation by NAC may also explain the attenuated lymphocyte apoptosis by thiol-based antioxidants. Interestingly, exercise training results in improved GSH metabolism and antioxidant capacity and reduced TNF<italic>&#x003b1;</italic>-induced apoptosis [<xref rid="B105" ref-type="bibr">105</xref>]. Treatment of cells with thiol-based antioxidants (GSH, cysteine, and NAC) abolishes NF-<italic>&#x003ba;</italic>B activation [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B106" ref-type="bibr">106</xref>] due to an inhibition of TNFa-induced activation of NF-<italic>&#x003ba;</italic>B and specifically to an attenuation of TNFa binding to its receptor [<xref rid="B107" ref-type="bibr">107</xref>]. Moreover, NAC pretreatment of macrophages was able to prevent a rise of free p50/p65 heterodimers following exposure to ionizing radiation [<xref rid="B108" ref-type="bibr">108</xref>]. In fact, NAC has been shown to inhibit the transfer of p65 protein to the nucleus from cytoplasm in piglets [<xref rid="B109" ref-type="bibr">109</xref>]. In line with these observations, NAC inhibited IKKa/b and IkBa phosphorylation and thus the stimulation of NF-<italic>&#x003ba;</italic>B in endothelial cells following exposure to silver nanoparticles [<xref rid="B110" ref-type="bibr">110</xref>]. Other sulfur-containing antioxidants such as pyrrolidine dithiocarbamate have also been shown to inhibit NF-<italic>&#x003ba;</italic>B after exercise due to a partial reduction of nuclear NF-kB binding, a complete inhibition of IkBa phosphorylation, and degradation and a rise of p50 concentration in the nucleus [<xref rid="B111" ref-type="bibr">111</xref>]. In general, antioxidants are capable of reducing peroxide-stimulated NF-<italic>&#x003ba;</italic>B activity [<xref rid="B112" ref-type="bibr">112</xref>]. These effects of thiol-based antioxidants are coupled with blunting of NF-<italic>&#x003ba;</italic>B transcriptional activity [<xref rid="B13" ref-type="bibr">13</xref>].</p><p>In contrast, Nielsen et al. [<xref rid="B90" ref-type="bibr">90</xref>] reported that the impaired NK cell activity and mitogen-stimulated lymphocyte proliferation were not abolished by NAC after exercise and failure of antioxidant supplements to attenuate exercise-induced lymphocytopenia was not prevented when other antioxidants were used. A cocktail of vitamins C and E failed to observe changes in exercise-induced changes of lymphocyte levels [<xref rid="B41" ref-type="bibr">41</xref>]. Furthermore, immune responses following a 2.5&#x02009;h run remained unaffected by vitamin C supplementation [<xref rid="B113" ref-type="bibr">113</xref>]. Contradictory results reported by these studies may be attributed to differences in exercise protocols used, the amount of muscle mass involved, and the degree of induced inflammation and lymphocyte apoptosis. For example, Nielsen et al. [<xref rid="B90" ref-type="bibr">90</xref>] used a 6-minute &#x0201c;all-out&#x0201d; ergometer rowing which is different than a 300-repetition eccentric exercise protocol in terms of metabolic requirements and degree of induced muscle damage and inflammatory responses.</p><p>In conclusion, our data provide evidence of a redox-dependent regulation of immune responses to skeletal muscle damage induced by intense eccentric exercise. The attenuation of immune responses following NAC consumption seems to be related to an enhancement of GSH levels that lead to redox status changes which ultimately results in changes of proinflammatory cytokines and adhesion molecules.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by departmental funding, a grant received by Bodosakis Foundation (Greece) for instrument purchase, and Grant Funding CE-80739. The authors need to thank Mr. Ioannis Galanis for his assistance with diet analysis.</p></ack><sec><title>Disclosure</title><p>The sponsors of the study had no role in the design, implementation, analysis, and interpretation of the data.</p></sec><sec sec-type="COI-statement"><title>Competing Interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' Contributions</title><p>Alexandra Sakelliou and Ioannis G. Fatouros contributed equally to this work.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tidball</surname><given-names>J. G.</given-names></name><name><surname>Villalta</surname><given-names>S. A.</given-names></name></person-group><article-title>Regulatory interactions between muscle and the immune system during muscle regeneration</article-title><source><italic>American Journal of Physiology&#x02014;Regulatory Integrative and Comparative Physiology</italic></source><year>2010</year><volume>298</volume><issue>5</issue><fpage>R1173</fpage><lpage>R1187</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00735.2009</pub-id><pub-id pub-id-type="other">2-s2.0-77951700255</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>C.</given-names></name><name><surname>Kruger</surname><given-names>M. J.</given-names></name><name><surname>Smith</surname><given-names>R. M.</given-names></name><name><surname>Myburgh</surname><given-names>K. H.</given-names></name></person-group><article-title>The inflammatory response to skeletal muscle injury: illuminating complexities</article-title><source><italic>Sports Medicine</italic></source><year>2008</year><volume>38</volume><issue>11</issue><fpage>947</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.2165/00007256-200838110-00005</pub-id><pub-id pub-id-type="other">2-s2.0-54249103012</pub-id><pub-id pub-id-type="pmid">18937524</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michailidis</surname><given-names>Y.</given-names></name><name><surname>Karagounis</surname><given-names>L. G.</given-names></name><name><surname>Terzis</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise</article-title><source><italic>The American Journal of Clinical Nutrition</italic></source><year>2013</year><volume>98</volume><issue>1</issue><fpage>233</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.3945/ajcn.112.049163</pub-id><pub-id pub-id-type="other">2-s2.0-84879451153</pub-id><pub-id pub-id-type="pmid">23719546</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raastad</surname><given-names>T.</given-names></name><name><surname>Owe</surname><given-names>S. G.</given-names></name><name><surname>Paulsen</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Changes in calpain activity, muscle structure, and function after eccentric exercise</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2010</year><volume>42</volume><issue>1</issue><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1249/mss.0b013e3181ac7afa</pub-id><pub-id pub-id-type="other">2-s2.0-73449090786</pub-id><pub-id pub-id-type="pmid">20010126</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehrenbach</surname><given-names>E.</given-names></name><name><surname>Schneider</surname><given-names>M. E.</given-names></name></person-group><article-title>Trauma-induced systemic inflammatory response versus exercise-induced immunomodulatory effects</article-title><source><italic>Sports Medicine</italic></source><year>2006</year><volume>36</volume><issue>5</issue><fpage>373</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.2165/00007256-200636050-00001</pub-id><pub-id pub-id-type="other">2-s2.0-33750943197</pub-id><pub-id pub-id-type="other">16646626</pub-id><pub-id pub-id-type="pmid">16646626</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fielding</surname><given-names>R. A.</given-names></name><name><surname>Manfredi</surname><given-names>T. J.</given-names></name><name><surname>Ding</surname><given-names>W.</given-names></name><name><surname>Fiatarone</surname><given-names>M. A.</given-names></name><name><surname>Evans</surname><given-names>W. J.</given-names></name><name><surname>Cannon</surname><given-names>J. G.</given-names></name></person-group><article-title>Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle</article-title><source><italic>The American Journal of Physiology</italic></source><year>1993</year><volume>265</volume><issue>1, part 2</issue><fpage>R166</fpage><lpage>R172</lpage><pub-id pub-id-type="pmid">8342683</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St Pierre</surname><given-names>B. A.</given-names></name><name><surname>Tidball</surname><given-names>J. G.</given-names></name></person-group><article-title>Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1994</year><volume>77</volume><issue>1</issue><fpage>290</fpage><lpage>297</lpage><pub-id pub-id-type="other">2-s2.0-0028234349</pub-id><pub-id pub-id-type="pmid">7961247</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlath</surname><given-names>G. K.</given-names></name><name><surname>Dominov</surname><given-names>J. A.</given-names></name><name><surname>Kegley</surname><given-names>K. M.</given-names></name><name><surname>Millert</surname><given-names>J. B.</given-names></name></person-group><article-title>Regeneration of transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix muscle regulatory factor MRF4</article-title><source><italic>American Journal of Pathology</italic></source><year>2003</year><volume>162</volume><issue>5</issue><fpage>1685</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64303-9</pub-id><pub-id pub-id-type="other">2-s2.0-0242500875</pub-id><pub-id pub-id-type="other">12707053</pub-id><pub-id pub-id-type="pmid">12707053</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulsen</surname><given-names>G.</given-names></name><name><surname>Mikkelsen</surname><given-names>U. R.</given-names></name><name><surname>Raastad</surname><given-names>T.</given-names></name><name><surname>Peake</surname><given-names>J. M.</given-names></name></person-group><article-title>Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise?</article-title><source><italic>Exercise Immunology Review</italic></source><year>2012</year><volume>18</volume><fpage>42</fpage><lpage>97</lpage><pub-id pub-id-type="other">2-s2.0-84862066322</pub-id><pub-id pub-id-type="pmid">22876722</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isanejad</surname><given-names>A.</given-names></name><name><surname>Saraf</surname><given-names>Z. H.</given-names></name><name><surname>Mahdavi</surname><given-names>M.</given-names></name><name><surname>Gharakhanlou</surname><given-names>R.</given-names></name><name><surname>Shamsi</surname><given-names>M. M.</given-names></name><name><surname>Paulsen</surname><given-names>G.</given-names></name></person-group><article-title>The effect of endurance training and downhill running on the expression of IL-1<italic>&#x003b2;</italic>, IL-6, and TNF-<italic>&#x003b1;</italic> and HSP72 in rat skeletal muscle</article-title><source><italic>Cytokine</italic></source><year>2015</year><volume>73</volume><issue>2</issue><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="other">2-s2.0-84926483843</pub-id><pub-id pub-id-type="pmid">25863030</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peake</surname><given-names>J.</given-names></name><name><surname>Nosaka</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name></person-group><article-title>Characterization of inflammatory responses to eccentric exercise in humans</article-title><source><italic>Exercise Immunology Review</italic></source><year>2005</year><volume>11</volume><fpage>64</fpage><lpage>85</lpage><pub-id pub-id-type="other">2-s2.0-33646378696</pub-id><pub-id pub-id-type="other">16385845</pub-id><pub-id pub-id-type="pmid">16385845</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigala</surname><given-names>I.</given-names></name><name><surname>Zacharatos</surname><given-names>P.</given-names></name><name><surname>Toumpanakis</surname><given-names>D.</given-names></name><etal/></person-group><article-title>MAPKs and NF-<italic>&#x003ba;</italic>B differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress</article-title><source><italic>American Journal of Physiology&#x02014;Regulatory Integrative and Comparative Physiology</italic></source><year>2011</year><volume>300</volume><issue>5</issue><fpage>R1152</fpage><lpage>R1162</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00376.2010</pub-id><pub-id pub-id-type="other">2-s2.0-79955781453</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlahopoulos</surname><given-names>S.</given-names></name><name><surname>Boldogh</surname><given-names>I.</given-names></name><name><surname>Casola</surname><given-names>A.</given-names></name><name><surname>Brasier</surname><given-names>A. R.</given-names></name></person-group><article-title>Nuclear factor-<italic>&#x003ba;</italic>B-dependent induction of interleukin-8 gene expression by tumor necrosis factor <italic>&#x003b1;</italic>: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation</article-title><source><italic>Blood</italic></source><year>1999</year><volume>94</volume><issue>6</issue><fpage>1878</fpage><lpage>1889</lpage><pub-id pub-id-type="other">2-s2.0-0033567455</pub-id><pub-id pub-id-type="pmid">10477716</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vezzoli</surname><given-names>M.</given-names></name><name><surname>Castellani</surname><given-names>P.</given-names></name><name><surname>Campana</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Redox remodeling: a candidate regulator of HMGB1 function in injured skeletal muscle</article-title><source><italic>Annals of the New York Academy of Sciences</italic></source><year>2010</year><volume>1209</volume><issue>1</issue><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05748.x</pub-id><pub-id pub-id-type="other">2-s2.0-78049488758</pub-id><pub-id pub-id-type="pmid">20958320</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizza</surname><given-names>F. X.</given-names></name><name><surname>Mitchell</surname><given-names>J. B.</given-names></name><name><surname>Davis</surname><given-names>B. H.</given-names></name><name><surname>Starling</surname><given-names>R. D.</given-names></name><name><surname>Holtz</surname><given-names>R. W.</given-names></name><name><surname>Bigelow</surname><given-names>N.</given-names></name></person-group><article-title>Exercise-induced muscle damage: effect on circulating leukocyte and lymphocyte subsets</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>1995</year><volume>27</volume><issue>3</issue><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="other">2-s2.0-0028908003</pub-id><pub-id pub-id-type="pmid">7752863</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>D. C.</given-names></name><name><surname>Simondie</surname><given-names>S.</given-names></name><name><surname>Henson</surname><given-names>D. A.</given-names></name><etal/></person-group><article-title>Lymphocyte proliferative response to 2.5&#x02009;hours of running</article-title><source><italic>International Journal of Sports Medicine</italic></source><year>1995</year><volume>16</volume><issue>6</issue><fpage>404</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1055/s-2007-973028</pub-id><pub-id pub-id-type="other">2-s2.0-0028984424</pub-id><pub-id pub-id-type="pmid">7591393</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>R. J.</given-names></name><name><surname>Florida-James</surname><given-names>G. D.</given-names></name><name><surname>Whyte</surname><given-names>G. P.</given-names></name><name><surname>Guy</surname><given-names>Z. K.</given-names></name></person-group><article-title>The effects of intensive, moderate and downhill treadmill running on human blood lymphocytes expressing the adhesion/activation molecules CD54 (ICAM-1), CD18 (<italic>&#x003b2;</italic>
<sub>2</sub> integrin) and CD53</article-title><source><italic>European Journal of Applied Physiology</italic></source><year>2006</year><volume>97</volume><issue>1</issue><fpage>109</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1007/s00421-006-0146-4</pub-id><pub-id pub-id-type="other">2-s2.0-33745442839</pub-id><pub-id pub-id-type="pmid">16506060</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>B. K.</given-names></name><name><surname>Ullum</surname><given-names>H.</given-names></name></person-group><article-title>NK cell response to physical activity: possible mechanisms of action</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>1994</year><volume>26</volume><issue>2</issue><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1249/00005768-199402000-00003</pub-id><pub-id pub-id-type="other">2-s2.0-0028006446</pub-id><pub-id pub-id-type="pmid">8164530</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname><given-names>J. M.</given-names></name><name><surname>Jones</surname><given-names>D. A.</given-names></name><name><surname>Cambridge</surname><given-names>G.</given-names></name></person-group><article-title>Cellular infiltrates in human skeletal muscle: exercise induced damage as a model for inflammatory muscle disease?</article-title><source><italic>Journal of the Neurological Sciences</italic></source><year>1987</year><volume>82</volume><issue>1&#x02013;3</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/0022-510x(87)90002-5</pub-id><pub-id pub-id-type="other">2-s2.0-0023503144</pub-id><pub-id pub-id-type="pmid">3440861</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malm</surname><given-names>C.</given-names></name><name><surname>Nyberg</surname><given-names>P.</given-names></name><name><surname>Engstr&#x000f6;m</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies</article-title><source><italic>The Journal of Physiology</italic></source><year>2000</year><volume>529</volume><issue>1</issue><fpage>243</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00243.x</pub-id><pub-id pub-id-type="other">2-s2.0-0034668865</pub-id><pub-id pub-id-type="pmid">11080266</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>A. G.</given-names></name><name><surname>Arahata</surname><given-names>K.</given-names></name></person-group><article-title>Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies</article-title><source><italic>Human Pathology</italic></source><year>1986</year><volume>17</volume><issue>7</issue><fpage>704</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/s0046-8177(86)80180-0</pub-id><pub-id pub-id-type="other">2-s2.0-0022510445</pub-id><pub-id pub-id-type="pmid">3459704</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>D. C.</given-names></name></person-group><article-title>Exercise, upper respiratory tract infection, and the immune system</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>1994</year><volume>26</volume><issue>2</issue><fpage>128</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1249/00005768-199402000-00002</pub-id><pub-id pub-id-type="other">2-s2.0-0028118425</pub-id><pub-id pub-id-type="other">8164529</pub-id><pub-id pub-id-type="pmid">8164529</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanimura</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>K.</given-names></name><name><surname>Tanabe</surname><given-names>K.</given-names></name><name><surname>Kono</surname><given-names>I.</given-names></name><name><surname>Ajisaka</surname><given-names>R.</given-names></name></person-group><article-title>Effects of three consecutive days exercise on lymphocyte DNA damage in young men</article-title><source><italic>European Journal of Applied Physiology</italic></source><year>2010</year><volume>110</volume><issue>2</issue><fpage>307</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1007/s00421-010-1499-2</pub-id><pub-id pub-id-type="other">2-s2.0-77956617927</pub-id><pub-id pub-id-type="other">20473683</pub-id><pub-id pub-id-type="pmid">20473683</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Cabrera</surname><given-names>M.-C.</given-names></name><name><surname>Borr&#x000e1;s</surname><given-names>C.</given-names></name><name><surname>Pallardo</surname><given-names>F. V.</given-names></name><name><surname>Sastre</surname><given-names>J.</given-names></name><name><surname>Ji</surname><given-names>L. L.</given-names></name><name><surname>Vi&#x000f1;a</surname><given-names>J.</given-names></name></person-group><article-title>Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats</article-title><source><italic>The Journal of Physiology</italic></source><year>2005</year><volume>567</volume><issue>1</issue><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2004.080564</pub-id><pub-id pub-id-type="other">2-s2.0-23844540597</pub-id><pub-id pub-id-type="pmid">15932896</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolaidis</surname><given-names>M. G.</given-names></name><name><surname>Jamurtas</surname><given-names>A. Z.</given-names></name><name><surname>Paschalis</surname><given-names>V.</given-names></name><name><surname>Fatouros</surname><given-names>I. G.</given-names></name><name><surname>Koutedakis</surname><given-names>Y.</given-names></name><name><surname>Kouretas</surname><given-names>D.</given-names></name></person-group><article-title>The effect of muscle-damaging exercise on blood and skeletal muscle oxidative stress: magnitude and time-course considerations</article-title><source><italic>Sports Medicine</italic></source><year>2008</year><volume>38</volume><issue>7</issue><fpage>579</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.2165/00007256-200838070-00005</pub-id><pub-id pub-id-type="other">2-s2.0-45549092340</pub-id><pub-id pub-id-type="pmid">18557660</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>L. L.</given-names></name></person-group><article-title>Antioxidant signaling in skeletal muscle</article-title><source><italic>Experimental Gerontology</italic></source><year>2007</year><volume>42</volume><issue>7</issue><fpage>582</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2007.03.002</pub-id><pub-id pub-id-type="other">2-s2.0-34248573796</pub-id><pub-id pub-id-type="pmid">17467943</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L. Z.-H.</given-names></name><name><surname>Johnson</surname><given-names>A. P.</given-names></name><name><surname>Rando</surname><given-names>T. A.</given-names></name></person-group><article-title>NF<italic>&#x003ba;</italic>B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2001</year><volume>31</volume><issue>11</issue><fpage>1405</fpage><lpage>1416</lpage><pub-id pub-id-type="doi">10.1016/s0891-5849(01)00719-5</pub-id><pub-id pub-id-type="other">2-s2.0-0035578227</pub-id><pub-id pub-id-type="pmid">11728812</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>E. W.</given-names></name><name><surname>Ostrowski</surname><given-names>K.</given-names></name><name><surname>Ibfelt</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Effect of vitamin supplementation on cytokine response and on muscle damage after strenuous exercise</article-title><source><italic>American Journal of Physiology-Cell Physiology</italic></source><year>2001</year><volume>280</volume><issue>6</issue><fpage>C1570</fpage><lpage>C1575</lpage><pub-id pub-id-type="other">2-s2.0-0034990510</pub-id><pub-id pub-id-type="pmid">11350752</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milara</surname><given-names>J.</given-names></name><name><surname>Juan</surname><given-names>G.</given-names></name><name><surname>Peir&#x000f3;</surname><given-names>T.</given-names></name><name><surname>Serrano</surname><given-names>A.</given-names></name><name><surname>Cortijo</surname><given-names>J.</given-names></name></person-group><article-title>Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy</article-title><source><italic>Respiration</italic></source><year>2012</year><volume>83</volume><issue>2</issue><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1159/000332834</pub-id><pub-id pub-id-type="other">2-s2.0-84856476676</pub-id><pub-id pub-id-type="pmid">22094549</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>R.</given-names></name><name><surname>Shimizu</surname><given-names>M. H. M.</given-names></name><name><surname>Volpini</surname><given-names>R. A.</given-names></name><etal/></person-group><article-title>N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation</article-title><source><italic>American Journal of Physiology&#x02014;Lung Cellular and Molecular Physiology</italic></source><year>2012</year><volume>302</volume><issue>7</issue><fpage>L640</fpage><lpage>L650</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00097.2011</pub-id><pub-id pub-id-type="other">2-s2.0-84859470521</pub-id><pub-id pub-id-type="pmid">22268121</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>H.-H.</given-names></name><name><surname>Lee</surname><given-names>W.-R.</given-names></name><name><surname>Wang</surname><given-names>P.-H.</given-names></name><name><surname>Cheng</surname><given-names>K.-T.</given-names></name><name><surname>Chen</surname><given-names>Y.-C.</given-names></name><name><surname>Shen</surname><given-names>S.-C.</given-names></name></person-group><article-title>Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-<italic>&#x003ba;</italic>B and AP-1 activation in macrophages</article-title><source><italic>Journal of Dermatological Science</italic></source><year>2013</year><volume>69</volume><issue>2</issue><fpage>122</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2012.10.009</pub-id><pub-id pub-id-type="other">2-s2.0-84873567817</pub-id><pub-id pub-id-type="other">23178030</pub-id><pub-id pub-id-type="pmid">23178030</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacio</surname><given-names>J. R.</given-names></name><name><surname>Markert</surname><given-names>U. R.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>P.</given-names></name></person-group><article-title>Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide- activated macrophages</article-title><source><italic>Inflammation Research</italic></source><year>2011</year><volume>60</volume><issue>7</issue><fpage>695</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1007/s00011-011-0323-8</pub-id><pub-id pub-id-type="other">2-s2.0-80051665519</pub-id><pub-id pub-id-type="other">21424515</pub-id><pub-id pub-id-type="pmid">21424515</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadrilatero</surname><given-names>J.</given-names></name><name><surname>Hoffman-Goetz</surname><given-names>L.</given-names></name></person-group><article-title>N-Acetyl-L-Cysteine inhibits exercise-induced lymphocyte apoptotic protein alterations</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2005</year><volume>37</volume><issue>1</issue><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1249/01.mss.0000149809.95484.3d</pub-id><pub-id pub-id-type="other">2-s2.0-11344269947</pub-id><pub-id pub-id-type="pmid">15632668</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terzis</surname><given-names>G.</given-names></name><name><surname>Stratakos</surname><given-names>G.</given-names></name><name><surname>Manta</surname><given-names>P.</given-names></name><name><surname>Georgiadis</surname><given-names>G.</given-names></name></person-group><article-title>Throwing performance after resistance training and detraining</article-title><source><italic>Journal of Strength and Conditioning Research</italic></source><year>2008</year><volume>22</volume><issue>4</issue><fpage>1198</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1519/JSC.0b013e31816d5c97</pub-id><pub-id pub-id-type="other">2-s2.0-51249098367</pub-id><pub-id pub-id-type="other">18545188</pub-id><pub-id pub-id-type="pmid">18545188</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>C. K.</given-names></name><name><surname>Packer</surname><given-names>L.</given-names></name></person-group><article-title>Thiol homeostasis and supplements in physical exercise</article-title><source><italic>American Journal of Clinical Nutrition</italic></source><year>2000</year><volume>72</volume><issue>supplement 2</issue><fpage>653S</fpage><lpage>669S</lpage><pub-id pub-id-type="other">2-s2.0-0033837781</pub-id><pub-id pub-id-type="pmid">10919972</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medved</surname><given-names>I.</given-names></name><name><surname>Brown</surname><given-names>M. J.</given-names></name><name><surname>Bjorksten</surname><given-names>A. R.</given-names></name><name><surname>Leppik</surname><given-names>J. A.</given-names></name><name><surname>Sostaric</surname><given-names>S.</given-names></name><name><surname>McKenna</surname><given-names>M. J.</given-names></name></person-group><article-title>N-acetylcysteine infusion alters blood redox status but not time to fatigue during intense exercise in humans</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2003</year><volume>94</volume><issue>4</issue><fpage>1572</fpage><lpage>1582</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00884.2002</pub-id><pub-id pub-id-type="other">2-s2.0-0037377633</pub-id><pub-id pub-id-type="pmid">12496140</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbas</surname><given-names>I.</given-names></name><name><surname>Fatouros</surname><given-names>I. G.</given-names></name><name><surname>Douroudos</surname><given-names>I. I.</given-names></name><etal/></person-group><article-title>Physiological and performance adaptations of elite Greco-Roman wrestlers during a one-day tournament</article-title><source><italic>European Journal of Applied Physiology</italic></source><year>2011</year><volume>111</volume><issue>7</issue><fpage>1421</fpage><lpage>1436</lpage><pub-id pub-id-type="doi">10.1007/s00421-010-1761-7</pub-id><pub-id pub-id-type="other">2-s2.0-80053953809</pub-id><pub-id pub-id-type="other">21161266</pub-id><pub-id pub-id-type="pmid">21161266</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohr</surname><given-names>M.</given-names></name><name><surname>Draganidis</surname><given-names>D.</given-names></name><name><surname>Chatzinikolaou</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Muscle damage, inflammatory, immune and performance responses to three football games in 1 week in competitive male players</article-title><source><italic>European Journal of Applied Physiology</italic></source><year>2016</year><volume>116</volume><issue>1</issue><fpage>179</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1007/s00421-015-3245-2</pub-id><pub-id pub-id-type="other">2-s2.0-84952982169</pub-id><pub-id pub-id-type="pmid">26377004</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theodorou</surname><given-names>A. A.</given-names></name><name><surname>Nikolaidis</surname><given-names>M. G.</given-names></name><name><surname>Paschalis</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Comparison between glucose-6-phosphate dehydrogenase-deficient and normal individuals after eccentric exercise</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2010</year><volume>42</volume><issue>6</issue><fpage>1113</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181c67ecd</pub-id><pub-id pub-id-type="other">2-s2.0-77952528958</pub-id><pub-id pub-id-type="other">19997026</pub-id><pub-id pub-id-type="pmid">19997026</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorichter</surname><given-names>S.</given-names></name><name><surname>Martin</surname><given-names>M.</given-names></name><name><surname>Julius</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Effects of unaccustomed and accustomed exercise on the immune response in runners</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2006</year><volume>38</volume><issue>10</issue><fpage>1739</fpage><lpage>1745</lpage><pub-id pub-id-type="doi">10.1249/01.mss.0000230213.62743.fb</pub-id><pub-id pub-id-type="other">2-s2.0-33749492719</pub-id><pub-id pub-id-type="other">17019295</pub-id><pub-id pub-id-type="pmid">17019295</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>A. C.</given-names></name><name><surname>McKenna</surname><given-names>M. J.</given-names></name><name><surname>Medved</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Infusion with the antioxidant N-acetylcysteine attenuates early adaptive responses to exercise in human skeletal muscle</article-title><source><italic>Acta Physiologica</italic></source><year>2012</year><volume>204</volume><issue>3</issue><fpage>382</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.2011.02344.x</pub-id><pub-id pub-id-type="other">2-s2.0-84863392989</pub-id><pub-id pub-id-type="other">21827635</pub-id><pub-id pub-id-type="pmid">21827635</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgstr&#x000f6;m</surname><given-names>L.</given-names></name><name><surname>K&#x000e5;gedal</surname><given-names>B.</given-names></name></person-group><article-title>Dose dependent pharmacokinetics <italic>N</italic>-acetylcysteine after oral dosing to man</article-title><source><italic>Biopharmaceutics and Drug Disposition</italic></source><year>1990</year><volume>11</volume><issue>2</issue><fpage>131</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1002/bdd.2510110205</pub-id><pub-id pub-id-type="pmid">2328298</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Bjorksten</surname><given-names>A.</given-names></name><name><surname>Medved</surname><given-names>I.</given-names></name><name><surname>McKenna</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise</article-title><source><italic>European Journal of Clinical Pharmacology</italic></source><year>2004</year><volume>60</volume><issue>10</issue><fpage>717</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1007/s00228-004-0862-9</pub-id><pub-id pub-id-type="other">2-s2.0-12444339796</pub-id><pub-id pub-id-type="other">15619135</pub-id><pub-id pub-id-type="pmid">15619135</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>C. K.</given-names></name><name><surname>Marin</surname><given-names>E.</given-names></name><name><surname>Kretzschmar</surname><given-names>M.</given-names></name><name><surname>Hanninen</surname><given-names>O.</given-names></name></person-group><article-title>Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1992</year><volume>73</volume><issue>4</issue><fpage>1265</fpage><lpage>1272</lpage><pub-id pub-id-type="other">2-s2.0-0026779269</pub-id><pub-id pub-id-type="other">1360001</pub-id><pub-id pub-id-type="pmid">1360001</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medved</surname><given-names>I.</given-names></name><name><surname>Brown</surname><given-names>M. J.</given-names></name><name><surname>Bjorksten</surname><given-names>A. R.</given-names></name><etal/></person-group><article-title>N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2004</year><volume>97</volume><issue>4</issue><fpage>1477</fpage><lpage>1485</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00371.2004</pub-id><pub-id pub-id-type="other">2-s2.0-4644240045</pub-id><pub-id pub-id-type="other">15194675</pub-id><pub-id pub-id-type="pmid">15194675</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matuszczak</surname><given-names>Y.</given-names></name><name><surname>Farid</surname><given-names>M.</given-names></name><name><surname>Jones</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Effects of N-acetylcysteine on glutathione oxidation and fatigue during handgrip exercise</article-title><source><italic>Muscle and Nerve</italic></source><year>2005</year><volume>32</volume><issue>5</issue><fpage>633</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1002/mus.20385</pub-id><pub-id pub-id-type="other">2-s2.0-27144533632</pub-id><pub-id pub-id-type="other">16025522</pub-id><pub-id pub-id-type="pmid">16025522</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>R.</given-names></name><name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name></person-group><article-title>Differential rates of glutathione oxidation for assessment of cellular redox status and antioxidant capacity by capillary electrophoresis-mass spectrometry: an elusive biomarker of oxidative stress</article-title><source><italic>Analytical Chemistry</italic></source><year>2009</year><volume>81</volume><issue>16</issue><fpage>7047</fpage><lpage>7056</lpage><pub-id pub-id-type="doi">10.1021/ac901174g</pub-id><pub-id pub-id-type="other">2-s2.0-68849119822</pub-id><pub-id pub-id-type="pmid">19610656</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atalay</surname><given-names>M.</given-names></name><name><surname>Marnila</surname><given-names>P.</given-names></name><name><surname>Lilius</surname><given-names>E.</given-names></name><name><surname>Hanninen</surname><given-names>O.</given-names></name><name><surname>Sen</surname><given-names>C. K.</given-names></name></person-group><article-title>Glutathione-dependent modulation of exhausting exercise-induced changes in neutrophil function of rats</article-title><source><italic>European Journal of Applied Physiology and Occupational Physiology</italic></source><year>1996</year><volume>74</volume><issue>4</issue><fpage>342</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1007/bf02226931</pub-id><pub-id pub-id-type="other">2-s2.0-0029961237</pub-id><pub-id pub-id-type="pmid">8911827</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowska</surname><given-names>A. M.</given-names></name><name><surname>Manuel-Y-Keenoy</surname><given-names>B.</given-names></name><name><surname>Vertongen</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Effect of N-acetylcysteine on neutrophil activation markers in healthy volunteers: in vivo and in vitro study</article-title><source><italic>Pharmacological Research</italic></source><year>2006</year><volume>53</volume><issue>3</issue><fpage>216</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2005.11.003</pub-id><pub-id pub-id-type="other">2-s2.0-32844464158</pub-id><pub-id pub-id-type="pmid">16384711</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merry</surname><given-names>T. L.</given-names></name><name><surname>Wadley</surname><given-names>G. D.</given-names></name><name><surname>Stathis</surname><given-names>C. G.</given-names></name><etal/></person-group><article-title>N-Acetylcysteine infusion does not affect glucose disposal during prolonged moderate-intensity exercise in humans</article-title><source><italic>Journal of Physiology</italic></source><year>2010</year><volume>588</volume><issue>9</issue><fpage>1623</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2009.184333</pub-id><pub-id pub-id-type="other">2-s2.0-77952929323</pub-id><pub-id pub-id-type="other">20308250</pub-id><pub-id pub-id-type="pmid">20308250</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>S. J.</given-names></name><name><surname>Winyard</surname><given-names>P. G.</given-names></name><name><surname>Blackwell</surname><given-names>J. R.</given-names></name><etal/></person-group><article-title>Influence of N-acetylcysteine administration on pulmonary O<sub>2</sub> uptake kinetics and exercise tolerance in humans</article-title><source><italic>Respiratory Physiology &#x00026; Neurobiology</italic></source><year>2011</year><volume>175</volume><issue>1</issue><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2010.10.002</pub-id><pub-id pub-id-type="other">2-s2.0-78650169522</pub-id><pub-id pub-id-type="pmid">20937413</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>L. F.</given-names></name><name><surname>Campbell</surname><given-names>K. S.</given-names></name><name><surname>Reid</surname><given-names>M. B.</given-names></name></person-group><article-title>N-acetylcysteine in handgrip exercise: plasma thiols and adverse reactions</article-title><source><italic>International Journal of Sport Nutrition and Exercise Metabolism</italic></source><year>2011</year><volume>21</volume><issue>2</issue><fpage>146</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.21.2.146</pub-id><pub-id pub-id-type="other">2-s2.0-79955906531</pub-id><pub-id pub-id-type="pmid">21558576</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridgeman</surname><given-names>M. M. E.</given-names></name><name><surname>Marsden</surname><given-names>M.</given-names></name><name><surname>MacNee</surname><given-names>W.</given-names></name><name><surname>Flenley</surname><given-names>D. C.</given-names></name><name><surname>Ryle</surname><given-names>A. P.</given-names></name></person-group><article-title>Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine</article-title><source><italic>Thorax</italic></source><year>1991</year><volume>46</volume><issue>1</issue><fpage>39</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1136/thx.46.1.39</pub-id><pub-id pub-id-type="other">2-s2.0-0026029981</pub-id><pub-id pub-id-type="other">1871695</pub-id><pub-id pub-id-type="pmid">1871695</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arranz</surname><given-names>L.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>C.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>A.</given-names></name><name><surname>Ribera</surname><given-names>J. M.</given-names></name><name><surname>De la Fuente</surname><given-names>M.</given-names></name></person-group><article-title>The glutathione precursor N-acetylcysteine improves immune function in postmenopausal women</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2008</year><volume>45</volume><issue>9</issue><fpage>1252</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.07.014</pub-id><pub-id pub-id-type="other">2-s2.0-53449091546</pub-id><pub-id pub-id-type="other">18694818</pub-id><pub-id pub-id-type="pmid">18694818</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>C. K.</given-names></name><name><surname>Rankinen</surname><given-names>T.</given-names></name><name><surname>Vaisanen</surname><given-names>S.</given-names></name><name><surname>Rauramaa</surname><given-names>R.</given-names></name></person-group><article-title>Oxidative stress after human exercise: effect of N-acetylcysteine supplementation</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1994</year><volume>76</volume><issue>6</issue><fpage>2570</fpage><lpage>2577</lpage><pub-id pub-id-type="other">2-s2.0-0028282599</pub-id><pub-id pub-id-type="pmid">7928885</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>C. K.</given-names></name><name><surname>Atalay</surname><given-names>M.</given-names></name><name><surname>Hanninen</surname><given-names>O.</given-names></name></person-group><article-title>Exercise-induced oxidative stress: glutathione supplementation and deficiency</article-title><source><italic>Journal of Applied Physiology</italic></source><year>1994</year><volume>77</volume><issue>5</issue><fpage>2177</fpage><lpage>2187</lpage><pub-id pub-id-type="other">2-s2.0-0027970525</pub-id><pub-id pub-id-type="pmid">7868431</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>R.</given-names></name><name><surname>West</surname><given-names>D.</given-names></name><name><surname>Phillips</surname><given-names>S. M.</given-names></name><name><surname>Britz-McKibbin</surname><given-names>P.</given-names></name></person-group><article-title>Differential metabolomics for quantitative assessment of oxidative stress with strenuous exercise and nutritional intervention: thiol-specific regulation of cellular metabolism with N-acetyl-L-cysteine pretreatment</article-title><source><italic>Analytical Chemistry</italic></source><year>2010</year><volume>82</volume><issue>7</issue><fpage>2959</fpage><lpage>2968</lpage><pub-id pub-id-type="doi">10.1021/ac9029746</pub-id><pub-id pub-id-type="other">2-s2.0-77950417420</pub-id><pub-id pub-id-type="pmid">20192244</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macneil</surname><given-names>L. G.</given-names></name><name><surname>Baker</surname><given-names>S. K.</given-names></name><name><surname>Stevic</surname><given-names>I.</given-names></name><name><surname>Tarnopolsky</surname><given-names>M. A.</given-names></name></person-group><article-title>17<italic>&#x003b2;</italic>-estradiol attenuates exercise-induced neutrophil infiltration in men</article-title><source><italic>American Journal of Physiology-Regulatory Integrative and Comparative Physiology</italic></source><year>2011</year><volume>300</volume><issue>6</issue><fpage>1443</fpage><lpage>1451</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00689.2009</pub-id><pub-id pub-id-type="other">2-s2.0-79958813607</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandstr&#x000f6;m</surname><given-names>M. E.</given-names></name><name><surname>Zhang</surname><given-names>S.-J.</given-names></name><name><surname>Bruton</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle</article-title><source><italic>The Journal of Physiology</italic></source><year>2006</year><volume>575</volume><issue>1</issue><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2006.110601</pub-id><pub-id pub-id-type="other">2-s2.0-33746810466</pub-id><pub-id pub-id-type="pmid">16777943</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Qi</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>The effect of treadmill training and N-acetyl-L-cysteine intervention on biogenesis of cytochrome c oxidase (COX)</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2015</year><volume>87</volume><fpage>326</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.06.035</pub-id><pub-id pub-id-type="other">2-s2.0-84941198041</pub-id><pub-id pub-id-type="pmid">26159509</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyriakides</surname><given-names>C.</given-names></name><name><surname>Austen</surname><given-names>W.</given-names><suffix>Jr.</suffix></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex</article-title><source><italic>American Journal of Physiology-Cell Physiology</italic></source><year>1999</year><volume>277</volume><issue>6</issue><fpage>C1263</fpage><lpage>C1268</lpage><pub-id pub-id-type="other">2-s2.0-0033387867</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atalay</surname><given-names>M.</given-names></name><name><surname>Seene</surname><given-names>T.</given-names></name><name><surname>H&#x000e4;nninen</surname><given-names>O.</given-names></name><name><surname>Sen</surname><given-names>C. K.</given-names></name></person-group><article-title>Skeletal muscle and heart antioxidant defences in response to sprint training</article-title><source><italic>Acta Physiologica Scandinavica</italic></source><year>1996</year><volume>158</volume><issue>2</issue><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201x.1996.540305000.x</pub-id><pub-id pub-id-type="other">2-s2.0-0029817197</pub-id><pub-id pub-id-type="pmid">8899059</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobley</surname><given-names>J. N.</given-names></name><name><surname>McGlory</surname><given-names>C.</given-names></name><name><surname>Morton</surname><given-names>J. P.</given-names></name><name><surname>Close</surname><given-names>G. L.</given-names></name></person-group><article-title>N-acetylcysteine's attenuation of fatigue after repeated bouts of intermittent exercise: practical implications for tournament situations</article-title><source><italic>International Journal of Sport Nutrition and Exercise Metabolism</italic></source><year>2011</year><volume>21</volume><issue>6</issue><fpage>451</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.21.6.451</pub-id><pub-id pub-id-type="other">2-s2.0-81155131519</pub-id><pub-id pub-id-type="pmid">22089305</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>M. J.</given-names></name><name><surname>Medved</surname><given-names>I.</given-names></name><name><surname>Goodman</surname><given-names>C. A.</given-names></name><etal/></person-group><article-title>N-acetylcysteine attenuates the decline in muscle Na+, K+-pump activity and delays fatigue during prolonged exercise in humans</article-title><source><italic>The Journal of Physiology</italic></source><year>2006</year><volume>576</volume><issue>1</issue><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2006.115352</pub-id><pub-id pub-id-type="other">2-s2.0-33748905385</pub-id><pub-id pub-id-type="pmid">16840514</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes-Marcondes</surname><given-names>M. C. C.</given-names></name><name><surname>Tisdale</surname><given-names>M. J.</given-names></name></person-group><article-title>Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress</article-title><source><italic>Cancer Letters</italic></source><year>2002</year><volume>180</volume><issue>1</issue><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/S0304-3835(02)00006-X</pub-id><pub-id pub-id-type="other">2-s2.0-0037030584</pub-id><pub-id pub-id-type="other">11911972</pub-id><pub-id pub-id-type="pmid">11911972</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agten</surname><given-names>A.</given-names></name><name><surname>Maes</surname><given-names>K.</given-names></name><name><surname>Smuder</surname><given-names>A.</given-names></name><name><surname>Powers</surname><given-names>S. K.</given-names></name><name><surname>Decramer</surname><given-names>M.</given-names></name><name><surname>Gayan-Ramirez</surname><given-names>G.</given-names></name></person-group><article-title>N-Acetylcysteine protects the rat diaphragm from the decreased contractility associated with controlled mechanical ventilation</article-title><source><italic>Critical Care Medicine</italic></source><year>2011</year><volume>39</volume><issue>4</issue><fpage>777</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e318206cca9</pub-id><pub-id pub-id-type="other">2-s2.0-79953184238</pub-id><pub-id pub-id-type="other">21242791</pub-id><pub-id pub-id-type="pmid">21242791</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Servais</surname><given-names>S.</given-names></name><name><surname>Letexier</surname><given-names>D.</given-names></name><name><surname>Favier</surname><given-names>R.</given-names></name><name><surname>Duchamp</surname><given-names>C.</given-names></name><name><surname>Desplanches</surname><given-names>D.</given-names></name></person-group><article-title>Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis?</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2007</year><volume>42</volume><issue>5</issue><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2006.12.001</pub-id><pub-id pub-id-type="other">2-s2.0-33846807633</pub-id><pub-id pub-id-type="pmid">17291986</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>S. J.</given-names></name></person-group><article-title>Tissue destruction by neutrophils</article-title><source><italic>The New England Journal of Medicine</italic></source><year>1989</year><volume>320</volume><issue>6</issue><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1056/nejm198902093200606</pub-id><pub-id pub-id-type="other">2-s2.0-0024602827</pub-id><pub-id pub-id-type="pmid">2536474</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gores-Lindholm</surname><given-names>A. R.</given-names></name><name><surname>LeBlanc</surname><given-names>M. M.</given-names></name><name><surname>Causey</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Relationships between intrauterine infusion of N-acetylcysteine, equine endometrial pathology, neutrophil function, post-breeding therapy, and reproductive performance</article-title><source><italic>Theriogenology</italic></source><year>2013</year><volume>80</volume><issue>3</issue><fpage>218</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.theriogenology.2013.03.026</pub-id><pub-id pub-id-type="other">2-s2.0-84879886610</pub-id><pub-id pub-id-type="other">23623166</pub-id><pub-id pub-id-type="pmid">23623166</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasram</surname><given-names>M. M.</given-names></name><name><surname>Lamine</surname><given-names>A. J.</given-names></name><name><surname>Dhouib</surname><given-names>I. B.</given-names></name><etal/></person-group><article-title>Antioxidant and anti-inflammatory effects of N-acetylcysteine against malathion-induced liver damages and immunotoxicity in rats</article-title><source><italic>Life Sciences</italic></source><year>2014</year><volume>107</volume><issue>1-2</issue><fpage>50</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2014.04.033</pub-id><pub-id pub-id-type="other">2-s2.0-84902547989</pub-id><pub-id pub-id-type="other">24810974</pub-id><pub-id pub-id-type="pmid">24810974</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasu</surname><given-names>V. T.</given-names></name><name><surname>De Cruz</surname><given-names>S. J.</given-names></name><name><surname>Houghton</surname><given-names>J. S.</given-names></name><etal/></person-group><article-title>Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: focus on myeloperoxidase</article-title><source><italic>Free Radical Research</italic></source><year>2011</year><volume>45</volume><issue>2</issue><fpage>165</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.3109/10715762.2010.521154</pub-id><pub-id pub-id-type="other">2-s2.0-78651280483</pub-id><pub-id pub-id-type="pmid">20954832</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochat</surname><given-names>T.</given-names></name><name><surname>Lacroix</surname><given-names>J.-S.</given-names></name><name><surname>Jornot</surname><given-names>L.</given-names></name></person-group><article-title>N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells</article-title><source><italic>Journal of Cellular Physiology</italic></source><year>2004</year><volume>201</volume><issue>1</issue><fpage>106</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1002/jcp.20066</pub-id><pub-id pub-id-type="other">2-s2.0-4444252447</pub-id><pub-id pub-id-type="other">15281093</pub-id><pub-id pub-id-type="pmid">15281093</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>S.</given-names></name><name><surname>Kurihara</surname><given-names>S.</given-names></name><name><surname>Titchenal</surname><given-names>C. A.</given-names></name><name><surname>Ohtani</surname><given-names>M.</given-names></name></person-group><article-title>Suppression of exercise-induced neutrophilia and lymphopenia in athletes by cystine/theanine intake: a randomized, double-blind, placebo-controlled trial</article-title><source><italic>Journal of the International Society of Sports Nutrition</italic></source><year>2010</year><volume>7, article 23</volume><pub-id pub-id-type="doi">10.1186/1550-2783-7-23</pub-id><pub-id pub-id-type="other">2-s2.0-77952997541</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geudens</surname><given-names>N.</given-names></name><name><surname>Van De Wauwer</surname><given-names>C.</given-names></name><name><surname>Neyrinck</surname><given-names>A. P.</given-names></name><etal/></person-group><article-title>N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung</article-title><source><italic>The Journal of Heart and Lung Transplantation</italic></source><year>2007</year><volume>26</volume><issue>12</issue><fpage>1326</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1016/j.healun.2007.09.008</pub-id><pub-id pub-id-type="other">2-s2.0-37149041409</pub-id><pub-id pub-id-type="pmid">18096486</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>P. J.</given-names></name><name><surname>Shapiro</surname><given-names>S. D.</given-names></name><name><surname>Pauwels</surname><given-names>R. A.</given-names></name></person-group><article-title>Chronic obstructive pulmonary disease: molecular and cellular mechanisms</article-title><source><italic>The European Respiratory Journal</italic></source><year>2003</year><volume>22</volume><issue>4</issue><fpage>672</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1183/09031936.03.00040703</pub-id><pub-id pub-id-type="other">2-s2.0-0141928029</pub-id><pub-id pub-id-type="pmid">14582923</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whyte</surname><given-names>M. K. B.</given-names></name><name><surname>Hardwick</surname><given-names>S. J.</given-names></name><name><surname>Meagher</surname><given-names>L. C.</given-names></name><name><surname>Savill</surname><given-names>J. S.</given-names></name><name><surname>Haslett</surname><given-names>C.</given-names></name></person-group><article-title>Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>1993</year><volume>92</volume><issue>1</issue><fpage>446</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1172/jci116587</pub-id><pub-id pub-id-type="other">2-s2.0-0027275036</pub-id><pub-id pub-id-type="pmid">8392090</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csontos</surname><given-names>C.</given-names></name><name><surname>Rezman</surname><given-names>B.</given-names></name><name><surname>Foldi</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury</article-title><source><italic>Burns</italic></source><year>2011</year><volume>37</volume><issue>3</issue><fpage>453</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2010.10.008</pub-id><pub-id pub-id-type="other">2-s2.0-79952700323</pub-id><pub-id pub-id-type="other">21131132</pub-id><pub-id pub-id-type="pmid">21131132</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radomska-Le&#x0015b;niewska</surname><given-names>D. M.</given-names></name><name><surname>Sadowska</surname><given-names>A. M.</given-names></name><name><surname>Van Overveld</surname><given-names>F. J.</given-names></name><name><surname>Demkow</surname><given-names>U.</given-names></name><name><surname>Zieli&#x00144;ski</surname><given-names>J.</given-names></name><name><surname>De Backer</surname><given-names>W. A.</given-names></name></person-group><article-title>Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells</article-title><source><italic>Journal of Physiology and Pharmacology</italic></source><year>2006</year><volume>57</volume><issue>4</issue><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="other">2-s2.0-33750389091</pub-id><pub-id pub-id-type="pmid">17072061</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandolini</surname><given-names>L.</given-names></name><name><surname>Bertini</surname><given-names>R.</given-names></name><name><surname>Bizzarri</surname><given-names>C.</given-names></name><etal/></person-group><article-title>IL-1<italic>&#x003b2;</italic> primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>1996</year><volume>59</volume><issue>3</issue><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="other">2-s2.0-0029664557</pub-id><pub-id pub-id-type="other">8604023</pub-id><pub-id pub-id-type="pmid">8604023</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>C.-H.</given-names></name><name><surname>Yoo</surname><given-names>M.-H.</given-names></name><name><surname>You</surname><given-names>H.-J.</given-names></name><etal/></person-group><article-title>Transepithelial migration of neutrophils in response to leukotriene B4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade</article-title><source><italic>Journal of Immunology</italic></source><year>2003</year><volume>170</volume><issue>12</issue><fpage>6273</fpage><lpage>6279</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.170.12.6273</pub-id><pub-id pub-id-type="other">2-s2.0-0037604738</pub-id><pub-id pub-id-type="other">12794160</pub-id><pub-id pub-id-type="pmid">12794160</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>T.</given-names></name><name><surname>Yamamura</surname><given-names>K.</given-names></name><name><surname>Gotoh</surname><given-names>S.</given-names></name><name><surname>Kashimura</surname><given-names>M.</given-names></name><name><surname>Higashi</surname><given-names>K.</given-names></name></person-group><article-title>Concentration-dependent differential effects of <italic>N</italic>-acetyl-<sc>l</sc>-cysteine on the expression of HSP70 and metallothionein genes induced by cadmium in human amniotic cells</article-title><source><italic>Biochimica et Biophysica Acta (BBA)&#x02014;General Subjects</italic></source><year>1998</year><volume>1380</volume><issue>1</issue><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/s0304-4165(97)00144-x</pub-id><pub-id pub-id-type="other">2-s2.0-0032510288</pub-id><pub-id pub-id-type="pmid">9545559</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobashi</surname><given-names>K.</given-names></name><name><surname>Aihara</surname><given-names>M.</given-names></name><name><surname>Araki</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Regulation of LPS induced IL-12 production by IFN-<italic>&#x003b3;</italic> and IL-4 through intracellular glutathione status in human alveolar macrophages</article-title><source><italic>Clinical and Experimental Immunology</italic></source><year>2001</year><volume>124</volume><issue>2</issue><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.2001.01535.x</pub-id><pub-id pub-id-type="pmid">11422207</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000ed;ctor</surname><given-names>V. M.</given-names></name><name><surname>Rocha</surname><given-names>M.</given-names></name><name><surname>De la Fuente</surname><given-names>M.</given-names></name></person-group><article-title>Regulation of macrophage function by the antioxidant N-acetylcysteine in mouse-oxidative stress by endotoxin</article-title><source><italic>International Immunopharmacology</italic></source><year>2003</year><volume>3</volume><issue>1</issue><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/s1567-5769(02)00232-1</pub-id><pub-id pub-id-type="other">2-s2.0-0037240932</pub-id><pub-id pub-id-type="pmid">12538039</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>W.</given-names></name><name><surname>Shen</surname><given-names>T.</given-names></name><etal/></person-group><article-title>The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of rage, MMPs and NF-<italic>&#x003ba;</italic>B in ApoE-deficient Mice</article-title><source><italic>Journal of Atherosclerosis and Thrombosis</italic></source><year>2011</year><volume>18</volume><issue>11</issue><fpage>998</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.5551/jat.8870</pub-id><pub-id pub-id-type="other">2-s2.0-82455164407</pub-id><pub-id pub-id-type="other">21873804</pub-id><pub-id pub-id-type="pmid">21873804</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zeigler</surname><given-names>M. M.</given-names></name><name><surname>Lam</surname><given-names>G. K.</given-names></name><etal/></person-group><article-title>The role of the NADPH oxidase complex, p38 MARK, and Akt in regulating human monocyte/macrophage survival</article-title><source><italic>American Journal of Respiratory Cell and Molecular Biology</italic></source><year>2007</year><volume>36</volume><issue>1</issue><fpage>68</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2006-0165OC</pub-id><pub-id pub-id-type="other">2-s2.0-33846075802</pub-id><pub-id pub-id-type="other">16931806</pub-id><pub-id pub-id-type="pmid">16931806</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>K.</given-names></name><name><surname>Chung</surname><given-names>T. Y.</given-names></name><name><surname>Hyon</surname><given-names>J. Y.</given-names></name><name><surname>Koh</surname><given-names>J. W.</given-names></name><name><surname>Wee</surname><given-names>W. R.</given-names></name><name><surname>Shin</surname><given-names>Y. J.</given-names></name></person-group><article-title>Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells&#x02014;chemically injured keratocyte reaction</article-title><source><italic>Molecular Vision</italic></source><year>2011</year><volume>17</volume><fpage>2665</fpage><lpage>2671</lpage><pub-id pub-id-type="other">2-s2.0-83055174011</pub-id><pub-id pub-id-type="pmid">22065919</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oddera</surname><given-names>S.</given-names></name><name><surname>Silvestri</surname><given-names>M.</given-names></name><name><surname>Sacco</surname><given-names>O.</given-names></name><name><surname>Eftimiadi</surname><given-names>C.</given-names></name><name><surname>Rossi</surname><given-names>G. A.</given-names></name></person-group><article-title>N-Acetylcysteine enhances in vitro the intracellular killing of <italic>Staphylococcus aureus</italic> by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing</article-title><source><italic>The Journal of Laboratory and Clinical Medicine</italic></source><year>1994</year><volume>124</volume><issue>2</issue><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="other">2-s2.0-0028484523</pub-id><pub-id pub-id-type="pmid">8051494</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadrilatero</surname><given-names>J.</given-names></name><name><surname>Hoffman-Goetz</surname><given-names>L.</given-names></name></person-group><article-title>N-Acetyl-L-cysteine prevents exercise-induced intestinal lymphocyte apoptosis by maintaining intracellular glutathione levels and reducing mitochondrial membrane depolarization</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2004</year><volume>319</volume><issue>3</issue><fpage>894</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.05.068</pub-id><pub-id pub-id-type="other">2-s2.0-2942567952</pub-id><pub-id pub-id-type="other">15184067</pub-id><pub-id pub-id-type="pmid">15184067</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman-Goetz</surname><given-names>L.</given-names></name><name><surname>Quadrilatero</surname><given-names>J.</given-names></name></person-group><article-title>Treadmill exercise in mice increases intestinal lymphocyte loss via apoptosis</article-title><source><italic>Acta Physiologica Scandinavica</italic></source><year>2003</year><volume>179</volume><issue>3</issue><fpage>289</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201x.2003.01176.x</pub-id><pub-id pub-id-type="other">2-s2.0-0344873099</pub-id><pub-id pub-id-type="pmid">14616245</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>H. B.</given-names></name><name><surname>Secher</surname><given-names>N. H.</given-names></name><name><surname>Kappel</surname><given-names>M.</given-names></name><name><surname>Pedersen</surname><given-names>B. K.</given-names></name></person-group><article-title>N-acetylcysteine does not affect the lymphocyte proliferation and natural killer cell activity responses to exercise</article-title><source><italic>The American Journal of Physiology</italic></source><year>1998</year><volume>275</volume><issue>4</issue><fpage>R1227</fpage><lpage>R1231</lpage><pub-id pub-id-type="other">2-s2.0-0031738423</pub-id><pub-id pub-id-type="pmid">9756554</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucuk</surname><given-names>O.</given-names></name><name><surname>Stoner-Picking</surname><given-names>J.</given-names></name><name><surname>Yachnin</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Inhibition of NK cell-mediated cytotoxicity by oxysterols</article-title><source><italic>Cellular Immunology</italic></source><year>1992</year><volume>139</volume><issue>2</issue><fpage>541</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/0008-8749(92)90091-3</pub-id><pub-id pub-id-type="other">2-s2.0-0026518303</pub-id><pub-id pub-id-type="pmid">1733518</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>B. K.</given-names></name><name><surname>Kharazmi</surname><given-names>A.</given-names></name><name><surname>Svenson</surname><given-names>M.</given-names></name></person-group><article-title>Down-regulation of natural killer cell activity by autologous polymorphonuclear leucocytes</article-title><source><italic>Allergy</italic></source><year>1988</year><volume>43</volume><issue>1</issue><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1111/j.1398-9995.1988.tb02039.x</pub-id><pub-id pub-id-type="other">2-s2.0-0023866891</pub-id><pub-id pub-id-type="pmid">3344932</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000fc;ger</surname><given-names>K.</given-names></name><name><surname>Frost</surname><given-names>S.</given-names></name><name><surname>Most</surname><given-names>E.</given-names></name><name><surname>V&#x000f6;lker</surname><given-names>K.</given-names></name><name><surname>Pallauf</surname><given-names>J.</given-names></name><name><surname>Mooren</surname><given-names>F. C.</given-names></name></person-group><article-title>Exercise affects tissue lymphocyte apoptosis via redox-sensitive and Fas-dependent signaling pathways</article-title><source><italic>American Journal of Physiology&#x02014;Regulatory Integrative and Comparative Physiology</italic></source><year>2009</year><volume>296</volume><issue>5</issue><fpage>R1518</fpage><lpage>R1527</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.90994.2008</pub-id><pub-id pub-id-type="other">2-s2.0-66149104674</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>K.</given-names></name><name><surname>Hsu</surname><given-names>T.-G.</given-names></name><name><surname>Hsu</surname><given-names>K.-M.</given-names></name><etal/></person-group><article-title>Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2001</year><volume>31</volume><issue>11</issue><fpage>1465</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1016/s0891-5849(01)00729-8</pub-id><pub-id pub-id-type="other">2-s2.0-0035581422</pub-id><pub-id pub-id-type="pmid">11728819</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steensberg</surname><given-names>A.</given-names></name><name><surname>Morrow</surname><given-names>J.</given-names></name><name><surname>Toft</surname><given-names>A. D.</given-names></name><name><surname>Bruunsgaard</surname><given-names>H.</given-names></name><name><surname>Pedersen</surname><given-names>B. K.</given-names></name></person-group><article-title>Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes</article-title><source><italic>European Journal of Applied Physiology</italic></source><year>2002</year><volume>87</volume><issue>1</issue><fpage>38</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s00421-002-0584-6</pub-id><pub-id pub-id-type="other">2-s2.0-0036560824</pub-id><pub-id pub-id-type="pmid">12012074</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.-S.</given-names></name><name><surname>Kuo</surname><given-names>H.-L.</given-names></name><name><surname>Kuo</surname><given-names>C.-F.</given-names></name><name><surname>Wang</surname><given-names>S.-T.</given-names></name><name><surname>Yang</surname><given-names>B.-C.</given-names></name><name><surname>Chen</surname><given-names>H.-I.</given-names></name></person-group><article-title>Antioxidant administration inhibits exercise-induced thymocyte apoptosis in rats</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>1999</year><volume>31</volume><issue>11</issue><fpage>1594</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1097/00005768-199911000-00015</pub-id><pub-id pub-id-type="other">2-s2.0-0032727826</pub-id><pub-id pub-id-type="other">10589862</pub-id><pub-id pub-id-type="pmid">10589862</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>A.</given-names></name><name><surname>Nie&#x000df;</surname><given-names>A. M.</given-names></name><name><surname>Gr&#x000fc;nert-Fuchs</surname><given-names>M.</given-names></name><name><surname>Poch</surname><given-names>B.</given-names></name><name><surname>Speit</surname><given-names>G.</given-names></name></person-group><article-title>Vitamin E prevents exercise-induced DNA damage</article-title><source><italic>Mutation Research Letters</italic></source><year>1995</year><volume>346</volume><issue>4</issue><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/0165-7992(95)90035-7</pub-id><pub-id pub-id-type="other">2-s2.0-0028987776</pub-id><pub-id pub-id-type="other">7753111</pub-id><pub-id pub-id-type="pmid">7753111</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagranha</surname><given-names>C. J.</given-names></name><name><surname>Senna</surname><given-names>S. M.</given-names></name><name><surname>de Lima</surname><given-names>T. M.</given-names></name><etal/></person-group><article-title>Beneficial effect of glutamine on exerciseinduced apoptosis of rat neutrophils</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2004</year><volume>36</volume><issue>2</issue><fpage>210</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1249/01.mss.0000113490.98089.b1</pub-id><pub-id pub-id-type="other">2-s2.0-0842303451</pub-id><pub-id pub-id-type="pmid">14767242</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.-K.</given-names></name><name><surname>Yang</surname><given-names>K. D.</given-names></name><name><surname>Chuang</surname><given-names>H.</given-names></name><name><surname>Jan</surname><given-names>J.-T.</given-names></name><name><surname>Shaio</surname><given-names>M.-F.</given-names></name></person-group><article-title>Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels</article-title><source><italic>Clinical Immunology</italic></source><year>2002</year><volume>104</volume><issue>2</issue><fpage>151</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1006/clim.2002.5257</pub-id><pub-id pub-id-type="other">2-s2.0-0036051315</pub-id><pub-id pub-id-type="other">12165276</pub-id><pub-id pub-id-type="pmid">12165276</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Will</surname><given-names>Y.</given-names></name><name><surname>Kaetzel</surname><given-names>R. S.</given-names></name><name><surname>Brown</surname><given-names>M. K.</given-names></name><name><surname>Fraley</surname><given-names>T. S.</given-names></name><name><surname>Reed</surname><given-names>D. J.</given-names></name></person-group><article-title>In Vivo reversal of glutathione deficiency and susceptibility to in Vivo dexamethasone-induced apoptosis by N-acetylcysteine and L-2-oxothiazolidine-4-carboxylic acid, but not ascorbic acid, in thymocytes from <italic>&#x003b3;</italic>-glutamyltranspeptidase-deficient knockout mice</article-title><source><italic>Archives of Biochemistry and Biophysics</italic></source><year>2002</year><volume>397</volume><issue>2</issue><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1006/abbi.2001.2662</pub-id><pub-id pub-id-type="other">2-s2.0-0037082120</pub-id><pub-id pub-id-type="other">11795900</pub-id><pub-id pub-id-type="pmid">11795900</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>N.</given-names></name><name><surname>Ishii</surname><given-names>S.</given-names></name><name><surname>Kikuchi</surname><given-names>K.</given-names></name></person-group><article-title>Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells</article-title><source><italic>European Journal of Immunology</italic></source><year>1996</year><volume>26</volume><issue>5</issue><fpage>1164</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1002/eji.1830260530</pub-id><pub-id pub-id-type="other">2-s2.0-0030012411</pub-id><pub-id pub-id-type="other">8647182</pub-id><pub-id pub-id-type="pmid">8647182</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonomura</surname><given-names>N.</given-names></name><name><surname>McLaughlin</surname><given-names>K.</given-names></name><name><surname>Grimm</surname><given-names>L.</given-names></name><name><surname>Goldsby</surname><given-names>R. A.</given-names></name><name><surname>Osborne</surname><given-names>B. A.</given-names></name></person-group><article-title>Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity</article-title><source><italic>Journal of Immunology</italic></source><year>2003</year><volume>170</volume><issue>5</issue><fpage>2469</fpage><lpage>2478</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.170.5.2469</pub-id><pub-id pub-id-type="other">2-s2.0-0344211823</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooren</surname><given-names>F. C.</given-names></name><name><surname>Bl&#x000f6;ming</surname><given-names>D.</given-names></name><name><surname>Lechtermann</surname><given-names>A.</given-names></name><name><surname>Lerch</surname><given-names>M. M.</given-names></name><name><surname>V&#x000f6;lker</surname><given-names>K.</given-names></name></person-group><article-title>Lymphocyte apoptosis after exhaustive and moderate exercise</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2002</year><volume>93</volume><issue>1</issue><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01262.2001</pub-id><pub-id pub-id-type="other">2-s2.0-0035985981</pub-id><pub-id pub-id-type="other">12070198</pub-id><pub-id pub-id-type="pmid">12070198</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeuerle</surname><given-names>P. A.</given-names></name><name><surname>Henkel</surname><given-names>T.</given-names></name></person-group><article-title>Function and activation of NF-<italic>&#x003ba;</italic>B in the immune system</article-title><source><italic>Annual Review of Immunology</italic></source><year>1994</year><volume>12</volume><fpage>141</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1146/annurev.iy.12.040194.001041</pub-id><pub-id pub-id-type="other">2-s2.0-0028174061</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy Avula</surname><given-names>C. P.</given-names></name><name><surname>Muthukumar</surname><given-names>A. R.</given-names></name><name><surname>Zaman</surname><given-names>K.</given-names></name><name><surname>McCarter</surname><given-names>R.</given-names></name><name><surname>Fernandes</surname><given-names>G.</given-names></name></person-group><article-title>Inhibitory effects of voluntary wheel exercise on apoptosis in splenic lymphocyte subsets of C57BL/6 mice</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2001</year><volume>91</volume><issue>6</issue><fpage>2546</fpage><lpage>2552</lpage><pub-id pub-id-type="other">2-s2.0-0035192165</pub-id><pub-id pub-id-type="other">11717217</pub-id><pub-id pub-id-type="pmid">11717217</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S. K.</given-names></name><name><surname>Velusamy</surname><given-names>T.</given-names></name><name><surname>Croad</surname><given-names>J. L.</given-names></name><name><surname>Rains</surname><given-names>J. L.</given-names></name><name><surname>Bull</surname><given-names>R.</given-names></name></person-group><article-title>l-Cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-<italic>&#x003ba;</italic>B activation in the livers of Zucker diabetic rats</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2009</year><volume>46</volume><issue>12</issue><fpage>1633</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.03.014</pub-id><pub-id pub-id-type="other">2-s2.0-67349179553</pub-id><pub-id pub-id-type="pmid">19328229</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname><given-names>M.</given-names></name><name><surname>Miyashita</surname><given-names>H.</given-names></name><name><surname>Sakamoto</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Evidence that reactive oxygen species do not mediate NF-<italic>&#x003ba;</italic>B activation</article-title><source><italic>EMBO Journal</italic></source><year>2003</year><volume>22</volume><issue>13</issue><fpage>3356</fpage><lpage>3366</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg332</pub-id><pub-id pub-id-type="other">2-s2.0-0038601994</pub-id><pub-id pub-id-type="other">12839997</pub-id><pub-id pub-id-type="pmid">12839997</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pajonk</surname><given-names>F.</given-names></name><name><surname>Riess</surname><given-names>K.</given-names></name><name><surname>Sommer</surname><given-names>A.</given-names></name><name><surname>McBride</surname><given-names>W. H.</given-names></name></person-group><article-title>N-acetyl-L-cysteine inhibits 26S proteasome function: Implications for effects on NF-<italic>&#x003ba;</italic>B activation</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2002</year><volume>32</volume><issue>6</issue><fpage>536</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/s0891-5849(02)00743-8</pub-id><pub-id pub-id-type="other">2-s2.0-0037087050</pub-id><pub-id pub-id-type="pmid">11958954</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>The combination effects of acetaminophen and N-acetylcysteine on cytokines production and NF-<italic>&#x003ba;</italic>B activation of lipopolysaccharide-challenged piglet mononuclear phagocytes in vitro and in vivo</article-title><source><italic>Veterinary Immunology and Immunopathology</italic></source><year>2013</year><volume>152</volume><issue>3-4</issue><fpage>381</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2013.01.013</pub-id><pub-id pub-id-type="other">2-s2.0-84875536900</pub-id><pub-id pub-id-type="other">23434081</pub-id><pub-id pub-id-type="pmid">23434081</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK/NF-<italic>&#x003ba;</italic>B pathways</article-title><source><italic>Biomaterials</italic></source><year>2014</year><volume>35</volume><issue>24</issue><fpage>6657</fpage><lpage>6666</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.04.093</pub-id><pub-id pub-id-type="other">2-s2.0-84901394106</pub-id><pub-id pub-id-type="other">24818879</pub-id><pub-id pub-id-type="pmid">24818879</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>L. L.</given-names></name><name><surname>Gomez-Cabrera</surname><given-names>M.-C.</given-names></name><name><surname>Steinhafel</surname><given-names>N.</given-names></name><name><surname>Vina</surname><given-names>J.</given-names></name></person-group><article-title>Acute exercise activates nuclear factor (NF)-<italic>&#x003ba;</italic>B signaling pathway in rat skeletal muscle</article-title><source><italic>The FASEB Journal</italic></source><year>2004</year><volume>18</volume><issue>13</issue><fpage>1499</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1096/fj.04-1846com</pub-id><pub-id pub-id-type="other">2-s2.0-5044227528</pub-id><pub-id pub-id-type="pmid">15466358</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>H. F.</given-names></name><name><surname>Goodyear</surname><given-names>L. J.</given-names></name></person-group><article-title>Exercise, MAPK, and NF-<italic>&#x003ba;</italic>B signaling in skeletal muscle</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2007</year><volume>103</volume><issue>1</issue><fpage>388</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00085.2007</pub-id><pub-id pub-id-type="other">2-s2.0-34447632877</pub-id><pub-id pub-id-type="other">17303713</pub-id><pub-id pub-id-type="pmid">17303713</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>D. C.</given-names></name><name><surname>Henson</surname><given-names>D. A.</given-names></name><name><surname>Butterworth</surname><given-names>D. E.</given-names></name><etal/></person-group><article-title>Vitamin C supplementation does not alter the immune response to 2.5 hours of running</article-title><source><italic>International Journal of Sport Nutrition</italic></source><year>1997</year><volume>7</volume><issue>3</issue><fpage>173</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1123/ijsn.7.3.173</pub-id><pub-id pub-id-type="other">2-s2.0-0030819890</pub-id><pub-id pub-id-type="pmid">9286741</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The experimental design of the study. PLA, placebo; NAC, N-acetylcysteine.</p></caption><graphic xlink:href="OMCL2016-2840643.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Changes in redox status and oxidative stress markers in response to exercise-induced inflammation. PLA, placebo; NAC, N-acetylcysteine; GSH, reduced glutathione; GSSG, oxidized glutathione; TAC, total antioxidant capacity; PC, protein carbonyls; TBARS, thiobarbituric acid-reactive substances; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Changes of muscle performance and muscle damage markers. PLA, placebo; NAC, N-acetylcysteine; DOMS, delayed onset of muscle soreness; CK, creatine kinase activity; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Changes in inflammatory markers. PLA, placebo; NAC, N-acetylcysteine; CRP, C-reactive protein; sICAM-1, soluble intercellular adhesion molecule-1; sVCAM-1, vascular cell adhesion molecule-1; IL-1b, interleukin 1b; IL-6, interleukin 6; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Changes in leukocyte counts. PLA, placebo; NAC, N-acetylcysteine; WBC, white blood cell count; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Changes in the levels of T-helper cells, T cytotoxic cells, NK-T cells, and 62L macrophages. PLA, placebo; NAC, N-acetylcysteine; WBC, white blood cell count; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.006"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Changes in the levels of B lempho cells. PLA, placebo; NAC, N-acetylcysteine; WBC, white blood cell count; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.007"/></fig><fig id="fig8" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Changes in the levels of natural killer cells. PLA, placebo; NAC, N-acetylcysteine; WBC, white blood cell count; NK, natural killer; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.008"/></fig><fig id="fig9" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Changes in the levels of macrophages. PLA, placebo; NAC, N-acetylcysteine; WBC, white blood cell count; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.009"/></fig><fig id="fig10" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Changes in the levels of HLA<sup>+</sup>/Macr<sup>+</sup>macrophages. PLA, placebo; NAC, N-acetylcysteine; WBC, white blood cell count; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.010"/></fig><fig id="fig11" orientation="portrait" position="float"><label>Figure 11</label><caption><p>Changes in the levels of 11B<sup>+</sup> macrophages. PLA, placebo; NAC, N-acetylcysteine; WBC, white blood cell count; <sup>1</sup>significantly different from baseline at <italic>P</italic> &#x0003c; 0.05; <sup>2</sup>significantly different from the previous time point at <italic>P</italic> &#x0003c; 0.05; <sup>3</sup>significant difference between trials at <italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="OMCL2016-2840643.011"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Participants' characteristics during the study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">Placebo trial</th><th align="center" rowspan="1" colspan="1">NAC trial</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">24.6 &#x000b1; 2.5</td><td align="center" rowspan="1" colspan="1">24.9 &#x000b1; 2.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass (kg)</td><td align="center" rowspan="1" colspan="1">79.0 &#x000b1; 7.3</td><td align="center" rowspan="1" colspan="1">79.2 &#x000b1; 7.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Body height (m)</td><td align="center" rowspan="1" colspan="1">1.81 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">1.81 &#x000b1; 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">24.0 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">24.1 &#x000b1; 0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Body fat (%)</td><td align="center" rowspan="1" colspan="1">15.9 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">15.8 &#x000b1; 2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2max</sub> (mL/kg/min)</td><td align="center" rowspan="1" colspan="1">50.4 &#x000b1; 3.9</td><td align="center" rowspan="1" colspan="1">50.6 &#x000b1; 3.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Total daily energy intake (kcal)</td><td align="center" rowspan="1" colspan="1">2,782.2 &#x000b1; 255.0</td><td align="center" rowspan="1" colspan="1">2,764.2 &#x000b1; 237.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbohydrate daily intake (%)<sup>1</sup>
</td><td align="center" rowspan="1" colspan="1">59.4 &#x000b1; 3.2</td><td align="center" rowspan="1" colspan="1">59.1 &#x000b1; 2.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat daily intake (%)<sup>1</sup>
</td><td align="center" rowspan="1" colspan="1">24.8 &#x000b1; 1.1</td><td align="center" rowspan="1" colspan="1">24.6 &#x000b1; 1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein daily intake (%)<sup>1</sup>
</td><td align="center" rowspan="1" colspan="1">15.8 &#x000b1; 3.5</td><td align="center" rowspan="1" colspan="1">16.2 &#x000b1; 3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Selenium (mg/d)</td><td align="center" rowspan="1" colspan="1">47.5 &#x000b1; 3.3</td><td align="center" rowspan="1" colspan="1">47.2 &#x000b1; 3.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Zinc (mg/d)</td><td align="center" rowspan="1" colspan="1">13.5 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">13.9 &#x000b1; 1.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin C (mg/d)</td><td align="center" rowspan="1" colspan="1">132.3 &#x000b1; 9.8</td><td align="center" rowspan="1" colspan="1">131.8 &#x000b1; 8.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin E (mg/d)<sup>2</sup>
</td><td align="center" rowspan="1" colspan="1">9.2 &#x000b1; 1.1</td><td align="center" rowspan="1" colspan="1">9.3 &#x000b1; 0.9</td></tr></tbody></table><table-wrap-foot><fn><p>Values are presented as means &#x000b1; SDs. NAC, N-acetylcysteine; BMI, body mass index; VO<sub>2max</sub>, maximal oxygen consumption; <sup>1</sup>percent of total daily energy intake; <sup>2</sup>a-tocopherol equivalents.</p></fn></table-wrap-foot></table-wrap></floats-group></article>